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Abstract
RONAN ALLEN: Serum IgG Antibody Responses to Periodontal Pathogens 
among Pediatric Subjects
(Under the direction of Ceib Philips, Ph.D., Jessica Lee, D.D.S.,Ph.D., David 
Paquette, D.M.D., D.M.Sc., M.P.H).
The first part of this thesis details the results from an observational study of 303 
children 9-11 years of age. An immuno-checkerboard assay was used to analyze IgG 
levels for 18 different bacteria. Nearly half of the subjects tested positive for at least one 
orange complex bacteria and to A .actinomycetemcomitans. A higher proportion of 
females had positive IgG responses to 14 of the 18 bacteria. A significantly higher 
proportion of African Americans exhibited IgG responses for P. gingivalis, T. denticola, 
P. intermedia, P. nigrescens, A. actinomycetemcomitans and C. rectus (P<0.05). This
cross sectional study indicates that a sizable proportion of young patients may be exposed
and elicit an immune response to known periodontal pathogens. Recent evidence suggests 
that obesity and nutrition may be associated with periodontal disease. These two 
modifiable risk factors and their effects on periodontal disease are discussed in detail in 
the second part of this thesis.
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SERUM IgG ANTIBODY RESPONSES TO PERIODONTAL
PATHOGENS AMONG PEDIATRIC SUBJECTS
Abstract
The aim of this study is to assess prevalence of detectable serum immunoglobulin 
G (IgG) levels specific for periodontal bacteria in children and to compare the prevalence 
between gender and ethnic subcohorts. A subset of children 9-11 year olds were selected 
from the Cardiovascular Health in Children and Youth III (CHIC III) study, 75 with 
glucose levels ≥100mg/dL and 228 with glucose levels < 100mg/dL. Collected blood 
samples were analyzed for IgG levels for 18 different bacteria (oral and non-oral) using 
an immuno-checkerboard assay. Within this young cohort, 51.6% had positive IgG 
responses to at least one orange complex pathogen. Nearly half of the subjects tested 
positive for IgG to A.actinomycetemcomitans (46.6%). A higher proportion of females 
had positive IgG responses to 14 of the 18 bacteria (P<0.05). A higher proportion of 
African Americans exhibited IgG responses to 14 of the bacteria.  Differences were
statistically significant for P. gingivalis, T. denticola, P. intermedia, P. nigrescens, A. 
actinomycetemcomitans and C. rectus (P<0.05). This cross sectional study indicates that 
a sizable proportion of young patients may be exposed to and elicit an immune response 
to known periodontal pathogens. Within this study, a higher proportion of female and 
African American subjects had immune responses compared to males and Caucasians 
respectively.
2INTRODUCTION
The prevalence of periodontal disease in medically healthy children in North 
America varies from 0.4 - 0.8% for aggressive and 2.0 - 5.0% for chronic periodontitis 
(Albandar et al 2002). Prevalence rates for periodontitis prior to puberty vary from 0.84% 
to 26.9%. This variability is due to the limited number of case reports available for this 
age group (Oh et al. 2002). Gingivitis is affects a much greater proportion of children 
than periodontitis with estimates of greater than 70% for most populations studied (Oh et 
al. 2002). Prevalence rates for childhood periodontitis are higher among developing 
countries (MacGregor et al. 1986) and variations exist for different race and ethnic 
groups. Prevalence estimates for early onset or aggressive periodontitis range from 0.1 -
0.2% in Caucasians to as high as 3.0% in Africans and African Americans (Albandar et 
al. 2002). The effect of gender as a risk factor for periodontitis and the exact mode of 
inheritance of the disease remain uncertain. The available evidence suggests that young 
females in the peripubertal age may be more affected than males (Hørmand & Frandsen
1979); however, this effect is reduced or reversed with increasing age (Loe & Brown, 
1991) 
The oral bacterial biofilm is the primary etiological agent responsible for both 
gingivitis and periodontitis in children and adults (Löe et al. 1965, Moore et al. 1987). 
Although the oral biofilm can harbor a wide spectrum of bacterial types, it seems that 
only certain bacteria initiate and stimulate progression of periodontal disease (Socransky 
3et al. 1998). Putative periodontal pathogens in children include Aggregatibacter 
actinomycetemcomitans, Campylobacter rectus, Tanerella forsythia, Porphyromonas 
gingivalis, Prevotella intermedia, Prevotella nigrescens, Fusobacterium nucleatum and 
Treponema denticola (Van Winkelhoff et al. 2005). Within periodontitis subjects, these 
bacteria are recovered in higher numbers (Slots and Rams 1992), are associated with 
disease progression (Albandar et al. 1997) and possess potent virulence factors (Fives-
Taylor et al. 1999). Among the pathogenic bacteria, A. actinomycetemcomitans and P. 
gingivalis have been well documented as major players in the pathogenesis of aggressive 
forms of periodontal disease in children (Van Winkelhoff et al. 1989).  
The oral cavity becomes exposed to bacteria very early, and many commensal
organisms can be detected prior to tooth eruption (Bimstein & Matsson, 1999). The 
acquisition of oral bacteria includes horizontal and vertical transmissions as well as cross-
infection (Van Winkelhoff et al. 2005). Colonization of periodontal pathogens in the 
biofilm of young children is thought to be infrequent (Könönen et al. 2000). When it does 
occur, transmission and infection is thought to occur via maternal source (Watson et al. 
1996). In a cohort of 2 to 12-year-old children the prevalence of A. 
actinomycetemcomitans and P. gingivalis in plaque samples was 4.8% in healthy and 
20.0% for periodontitis subjects respectively (Okada et al. 2000). However, higher levels 
of colonization have been recently documented with 71% of 18 to 48-month-old children 
harboring at least one periodontal pathogen (Yang et al. 2002). The presence of 
periodontal pathogens in the biofilm may not be indicative of disease initiation and 
progression (Frisken et al. 1990, Okada et al. 2000). While, as their presence is necessary 
4for disease, their identification is still an inherent risk indicator for future periodontal 
diseases in a susceptible host (Socransky et al 1998). 
Immunoglobulin G antibodies (IgG) provide the majority of antibody-based 
immunity against invading pathogens and contribute to the inhibition of bacterial 
adherence and colonization, enhancing bacterial phagocytosis, via opsonization and 
agglutination (Kinane et al. 1999). Elevated serum IgG antibodies to A. 
actinomycetemcomitans have been reported in juvenile periodontitis (Zambon et al. 
1988), and to Porphyromonas gingivalis, Campylobacter rectus, Prevotella intermedia, 
and Tanerella  forsythia in adult periodontitis subjects compared to periodontally healthy 
subjects (Haffajee et al. 1995). Increases in antibody to colonizing pathogenic bacteria 
can be associated with subsequent progressing disease (Mouton et al. 1987, Ebersole & 
Taubman 1994).
IgG antibodies produced in response to periodontopathogens are increased in 
patients with clinical manifestations of periodontitis, and this reflects the subgingival 
colonization by the specific bacteria (Gunsolley et al. 1990, Nakagawa et al 1994a). 
Papapanou et al. 2001 reported 84% sensitivity and 57.5% specificity when using 
checkerboard assessments of serum IgG antibodies to oral bacteria as a surrogate for
periodontal disease status. In particular serum IgG levels to P. gingivalis, A.
actinomycetemcomitans and T. forsythensis have been shown to be elevated in adult 
patients with periodontitis compared to subjects without disease (Kinane et al. 1999,
Persson et al. 2000). Interestingly, reductions in serum IgG levels to P. gingivalis have 
been observed following successful therapy in patients with severe chronic periodontitis 
(Mooney et al. 1994). 
5It has been suggested that localized aggressive periodontitis patients produce 
elevated levels of IgG compared to generalized aggressive patients suggesting a 
protective role of the host in localizing attachment loss to a few teeth (Califano et al. 
1992). Other reports indicate elevated levels of serum antibodies with disease progression 
possible indicating production of an ineffective class of antibody (Albandar et al. 2001). 
A. actinomycetemcomitans and P. gingivalis have strong associations with chronic 
and aggressive forms of periodontitis and elevated serum IgG antibodies to these bacteria 
have been reported in children (Celenligil et al. 1998). Pathogenic strains of bacteria can 
be found in significant levels in the plaque of young children, eliciting a serum antibody 
response that increases with age, and may be related to incipient signs of periodontal 
disease (Bimstein et al. 2004). Differences in serum antibody response to 
periodontopathogens have been reported for different ethnic populations. Serum 
antibodies to A. actinomycetemcomitans were reported to be higher in African-Americans
than in Caucasians (Gunsolley et al. 1991).
The majority of studies examining IgG responses have focused on only a select 
few bacteria and no studies to date have reported the prevalence of serum IgG responses 
to a broad range of periodontopathogens in young children. More information on the 
acquisition of specific periodontal bacteria with concomitant immune responses in 
children could help to elucidate the development and pathogenesis of periodontitis. The 
aim of this cross sectional study is to measure the prevalence of serum IgG antibody 
responses against a broad range of oral and one non-oral bacteria for a population of 9-11 
year-old-children. 
6MATERIALS AND METHODS
Sample
Subjects for this cross sectional, observational study were selected from the 
Cardiovascular Health in Children and Youth III (CHIC III) study. A detailed description 
of the study design and objectives of the CHIC III study has previously been published 
(Ondrak et al. 2007). Briefly, 1,420 non-Hispanic African American or Caucasian 
participants were recruited from 34 schools that included a high proportion of minority 
students located in rural areas three regions (Eastern Coastal, Central Piedmont, and 
Western Mountain) in North Carolina. Demographic data were collected between January 
2000 and February 2003 at participants’ respective schools by teams of trained and 
calibrated research assistants. Consent was given for use of data and stored specimens in 
future research.
A subset of 320 children ranging in age from 9 to 11 years were selected for the 
analysis of IgG responses to periodontal bacteria after provision of assent and parental 
consent reviewed and approved by the Institutional Review Board of UNC-CH. The 
inclusion criteria consisted of ability to read and write English; and having at least one 
natural relative available to report family history. The exclusion criteria were 
7being physically handicapped as reported by parents, teachers, school nurses, or self; 
suffering from any serious illness such as type 1 diabetes requiring insulin, renal disease, 
or moderate to severe asthma as reported by parents, teachers, school, nurses, or self; 
having any major developmental disability as reported by parents. Seventy-five children 
in the cohort had elevated fasting glucose levels (≥100mg/dL).  For each of these 
“prediabetic” children, three children matched for normal fasting glucose levels 
(≤100mg/dl), age, sex, and race were randomly selected.
Analysis of serum IgG Responses
Serum samples were obtained by sterile venipuncture from each participant early 
in the morning after an overnight fast. Fasting compliance was confirmed by on-site 
research assistants. The blood samples (10ml) were allowed to clot for 2 hours at room 
temperature before centrifuging (20 minutes at approximately 2000 x g). Plasma and 
serum were separated and stored at -80°C until analysis. Specific IgG responses for 
periodontal pathogens were measured using an immuno-checkerboard (Sakellari et al. 
1997). Accordingly, pure colonies of known bacteria were grown on agar plates. Known 
bacteria from these colonies were added to 1 ml of phosphate buffered saline (PBS) in a 
1.5 ml Eppendorf tube. Bacterial cells were disrupted for 10 sec with an ultrasonic 
device. Nitrocellulose membranes were prepared, and the Miniblotter apparatus was pre-
chilled for 4 hours at 4°C. Membranes were equilibrated by soaking first in distilled 
water and then PBS for 10 minutes. Each membrane was loaded with bacterial 
suspensions (in duplicate) at 125 µl and protein A at 10µg/ml as a positive control 
(Boehringer, Germany). Miniblotter devices were incubated overnight at 4°C. Thereafter, 
8channels were emptied and washed with 500 ml TBS-T (NaCl, Trizma base at pH 7.6 and 
Tween 20). Membranes were dried at 37°C, blocked, washed, incubated for one hour 
with 100 ml of a solution containing distilled water (105 ml), 100% methanol (30 ml) and 
30% hydrogen peroxide (15 ml), and then washed and blocked again. Miniblotters were
mounted and rotated 90°, and channels were loaded with 130 µl of the unknown serum 
samples (diluted at 1/50, 1/1000 and 1/2000) and standards (IgG at various 
concentrations). Devices were incubated for one hour at room temperature, and then 
incubated with secondary antibody (Fab goat-anti-human IgG conjugated to HRP, 
Boehringer, Germany) for another hour at room temperature on a rotating table. 
Membranes were removed and washed with TBS-T. Equal volumes (25 ml) of ECL-
Western-blotting detection reagents (Amersham, Buckinghamshire, United Kingdom) 
were mixed and added to the membranes. Membranes were quickly wrapped in plastic, 
photographed and developed. Images were scanned, and the IgG response to each of 18 
bacteria, 17 periodontal pathogens (P. gingivalis, Prevetella intermedia, Prevetella 
nigrescens, Tanerella forsythensis, Treponema denticola, A. actinomycetemcomitans, 
Campylobacter rectus, Eikenella corrodens, Fusobacterium nucleatum, 
Peptostreptococcus micros, Capnopytophagia ochracea, Vionella parvula, 
Streptococcus. intermedius, Streptococcus oralis, Streptococus sanguis, Actinomyces 
viscosis, Streptococcus noxia) and one non-oral pathogen associated with gastritis and 
gastric ulcer (Helicobacter pylori) was scored dichotomously as detectable or not 
detectable (detectable threshold level >269.2 ng/mL was used). In addition to the 
individual bacteria responses, combinations of detectable bacteria were noted as present 
or absent for each subject.  The combinations considered were: two or more red complex 
9bacteria; two or more of the orange complex bacteria; at least one orange complex 
bacteria plus A. actinomycetemcomitans; at least one red complex bacteria plus A.
actinomycetemcomitans; at least one orange complex bacteria plus at least one red 
complex bacteria.
Statistical Analysis
Univariate statistics were used to summarize responses for the demographic and 
bacteria data.  The Chi-square test was used to compare the detectable proportion of each 
bacteria between males and females and between African-American and Caucasian 
children.  Fisher’s exact test was used to compare the presence of the combinations of 
bacteria between gender and ethnic subcohorts. 
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RESULTS
Description of Sample 
Seventeen of the initial 320 subjects could not be included due to incomplete 
sample collection, such as inadequate serum volume to perform IgG analysis. From the 
remaining 303 children studied, 72 (23.1%) were nine, 184 (59%) ten, and 56 (17.9%) 
eleven years old respectively. Forty-five percent (n=135) were female and 58% (n=176) 
were African-American (Table 1).  Four percent of the children reported having smoked. 
Mean fasting plasma glucose was calculated at 93.3 mg/dL ± SD 11.4 for the sample and 
24.8% (n=75) of the children were labeled as “pre-diabetic” with a fasting blood glucose 
of ≥100 mg/dL.
Prevalence of serum IgG response to individual bacteria 
The proportion of children with detectable bacterial threshold levels for all species 
examined ranged from 2.3% for F. nucleatum to 51.6% for P. intermedia (Table 2).  The 
percentage of IgG responses for red complex bacteria ranged from 5.9% for P. gingivalis
to 14.5% for T. denticola with orange complex responses highest for P. intermedia 
(51.6%) and lowest for F. nucleatum and S. noxia (both 2.3%). The percentage of 
children with IgG response to A. actinomycetemcomtans was 4.6.6%.  A higher 
proportion of girls had a positive IgG response to 14 of the individual pathogens (Table 
2). Compared to the boys, girls had elevated proportions of detectable thresholds for all 3
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red complex bacteria although this did not reach statistical significance. Within the other 
bacterial complexes statistically significant higher proportions of girls had IgG responses 
to two of the orange (P. micros and A. actinomycetemcomitans), one of the green (C.
oralis), two of the yellow complex bacteria (S. sobrinos, S. intermedia), and the gut 
bacterium H. pylori (p<0.05).
Table 1. Demographics of study sample
Variable Frequency
                             %         (n)
Gender
   Male 55.4% (168)
   Female 44.6% (135)
Race
   African American 58.1 % (176)
   Caucasian 41.9% (127)
Age (years) 
   9 22.8% (69)
   10 58.7% (178)
   11 18.5% (56)
Hyperglycemic (glucose ≥ 
100mg/dL) 
24.8% (75)
Smokers (current and former) 3.9 % (12)
Notably, a higher proportion of African Americans had a positive response to 14 
of the individual pathogens (Table 2). For the red complex bacteria, significantly higher 
proportions of IgG responses to T. denticola were found in African American children 
12
(19.9%) compared to Caucasians (7.1%) (P<0.005). IgG responses for P. gingivalis were 
also significantly elevated in African Americans when compared to Caucasians (P<0.05). 
Statistically significant elevations in the proportions of detectable thresholds were also 
observed for five of the orange complex bacteria (C. rectus, P. intermedia P. negriscens, 
and S. noxia) (P<0.05). IgG responses to P. nigrescens and P. intermedia were found to 
occur in more than twice the number of African Americans than Caucasians while IgG 
response to S. noxia was not detected in Caucasians but found in seven (4%) of the 
African American children. In addition, C. rectus was also detected in a low proportion 
of Caucasians (1.6%) while African Americans had significantly higher proportions 
(15.3%) (P<0.005). IgG specific for A. actinomycetemcomitans was observed in 99 
(56.3%) of African Americans versus only 42 (33.1%) of Caucasians (P<0.005) The 
difference in the proportion of detectable thresholds was not statistically significant for 
either the purple and yellow complex bacteria. 
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Table 2. Frequencies (n) of subjects with detectable levels of IgG
*Denotes statistically significance (Chi-squared test)
Bacteria All
(n=303)
Males
(n=168)
Females
(n=135)
p-value Caucasian
(n=127)
African
American
(n=176)
p-value
Red complex
5.9% (18) Pg 4.8%(8) 7.4%(10) 0.33 1.6%(2) 9.1%(16) 0.01* 
Tf 9.6% (29) 7.1%(12) 12.6%(17) 0.11 6.3%(8) 11.9%(21) 0.10 
Td 14.5%(44) 14.3%(24) 14.8%(20) 0.90 7.1%(9) 19.9%(35) 0.002* 
Orange
complex
Cr 9.6% (29) 7.7%(13) 11.9%(16) 0.23 1.6%(2) 15.3%(27) 0.0001* 
Pi 51.6%(157) 49.4%(83) 54.8%(74) 0.35 33.1%(42) 65.3%(115) 0.0001* 
Pn 15.5%(57) 15.5%(26) 15.6%(21) 0.98 7.9%(10) 21.0%(37) 0.002* 
Pm 12.5%(38) 8.3%(14) 17.8%(24) 0.01* 9.5%(12) 14.8%(26) 0.17 
Fn 2.3%(7) 2.4%(4) 2.2%(3) 0.93 0.8%(1) 3.4%(6) 0.13 
Aa 46.6%(141) 41.1%(69) 53.3%(72) 0.03* 33.1%(42) 56.3%(99) 0.0001* 
Sn 2.3%(7) 2.4%(4) 2.2%(3) 0.93 0%(0) 4.0%(7) 0.02* 
Purple
complex
Vp 2.3%(7) 1.8%(3) 3.0%(4) 0.50 1.6%(2) 2.8%(5) 0.47 
Green
complex
Ec 6.3%(19) 4.8%(8) 8.2%(11) 0.23 3.2%(4) 8.5%(15) 0.06 
Co 22.7%(69) 17.9%(30) 28.9%(39) 0.02* 17.3%(22) 26.7%(47) 0.04* 
Yellow
complex
Si 39.85%(121) 32.7%(55) 48.9%(66) 0.004* 42.5%(54) 38.1%(67) 0.44 
So 18.8%(57) 16.1%(27) 22.2%(30) 0.17 14.2%(18) 22.2%(39) 0.08 
Ss 5.6%(14) 1.8%(3) 8.2%(11) 0.009* 4.7%(6) 4.6%(8) 0.94 
Av 4.6%(14) 5.4%(9) 3.7%(5) 0.50 4.7%(6) 4.6%(8) 0.94 
Non-oral
Hp 6.3%(19) 2.4%(4) 11.1%(15) 0.002* 6.3%(8) 6.3%(11) 0.99 
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Prevalence of serum IgG response to combinations of bacteria
Twenty-one subjects (6.9%) had a positive IgG responses to at least two red 
complex bacteria, similarly, 69 (22.8%) subjects had IgG responses to at least two of the 
orange complex. A higher proportion of females were IgG positive for 6 of the 7 
combinations of bacteria, but girls and boys differed statistically only for all three of the 
red complex bacteria (p<0.05). Over one-third of the subjects (33.7%) had IgG responses 
to at least one orange complex bacteria in combination with A. actinomycetemcomitans. 
In contrast, 43 of the subjects (14.8%) had detectable IgG specific for at least one red 
complex pathogen in combination with A. actinomycetemcomitans (Table 3). 
Table 3. Frequencies (n) of subjects with detectable levels of IgG to different 
combinations of bacteria 
Groups of
Bacteria 
Subject groups
All 
(n=303) 
Males 
(n=168) 
Females 
(n=135) 
p-value Caucasian
(n=127) 
African 
American
(n=176) 
p-
value
Red Complex
At least 2 6.9% 
(21) 
4.8%(8) 9.6%(13) 0.10 3.2%(4) 9.7%(17) 0.03* 
All 3 1.0% 
(3) 
0%(0) 2.2%(3) 0.04* 0.8%(1) 1.1%(2) 0.76 
Orange complex
At least 2 22.8% 
(69) 
20.2%(34) 25.9%(35) 0.24 11.8%(15) 30.7%(54) 0.0001* 
3 or more 8.9% 
(27) 
8.9%(15) 8.9%(12) 0.99 0.8%(1) 14.8%(26) 0.0001* 
Other combinations
At least 1 Red +      
Aa
14.2% 
(43) 
13.7%(23) 14.8%(20) 0.78 5.5%(7) 20.5%(36) 0.0002* 
At least 1 Orange + 
Aa
33.7% 
(102) 
29.2%(49) 39.3%(53) 0.06 18.9%(24) 44.3%(78) 0.0001* 
At least 1 Orange + 
at least 1 red
18.8% 
(57) 
17.9%(30) 20.0%(27) 0.64 7.9%(10) 26.7%(47) 0.0001* 
*Denotes statistically significance (Fisher’s exact test)
15
Detectable IgG responses to one orange and one red complex bacteria was evident 
in 18.8% of the study sample. Again, a higher proportion of the African American 
children were positive for all seven of the combinations of bacteria with a statistically 
significant difference (P<0.05) observed for one of the seven combinations and highly 
significant (P<0.001) for five of the combinations of bacteria analyzed (Table 3). 
16
DISCUSSION
The overall hypothesis of our study is that exposure to periodontal pathogens and 
overweight/obesity is associated with increased systemic inflammation and hence 
increased diabetes risk in children. This first paper documents the prevalence of positive 
IgG responses to a number of periodontal pathogens. The rationale is that IgG antibody 
response represents an estimate of the overall systemic burden induced by periodontal 
infection. When combined with clinical periodontal measurements, these immune and 
other inflammatory responses could provide better estimates of the overall systemic 
burden imposed by an oral infectious challenge in chronic diseases such as diabetes.
The major finding of the present exploratory study is that the children in this 
cohort were exposed to and exhibited detectable immune responses to a broad range of 
known periodontal pathogens at an early age. This immune response against specific 
microorganisms can be used as evidence for exposure and impact of the microbial 
etiology on the pathogenesis of periodontitis (Kinane et al. 1999). Significantly more 
girls 9-11 years of age were likely to have IgG responses to one or more orange complex 
bacteria and A. actinomycetemcomitans as compared to boys. In addition, significantly 
more African Americans had IgG responses to both red and orange complex bacteria as 
well as A. actinomycetemcomitans versus white children.  
Early colonization of periodontal pathogens in the oral biofilm of children has 
been previously chronicled (Morinushi et al. 2000). Controversy still remains as to the 
percentages of children who harbor pathogenic bacteria, elicit an immune response and if 
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they are likely to develop periodontal disease.  In this study, the prevalence of positive 
IgG responses to P. gingivalis, T. forsythensis and T. denticola (red complex bacteria) 
was 5.9% (n=18), 9.6% (n=29) and 14.5% (n=44) respectively. Significant numbers of 
children exhibited IgG responses to at least one of the orange complex bacteria (51.6%). 
When combinations of bacteria were analyzed, it was apparent that over one-third of the 
children exhibted immune IgG responses to at least one orange complex bacteria in 
combination with A. actinomycetemcomitans. The last bacterium is most closely 
associated with localized aggressive periodontitis (Van Winkelhoff et al. 1989) and IgG 
responses were present in nearly half of the study population (46.6%). Children with A. 
actinomycetemcomitans associated aggressive periodontitis have an elevated IgG 
response in a high proportion of children (> 90%) (Ebersole et al. 1987).
The prevalence of pathogenic bacteria colonizing the oral biofilm of young 
subjects shows wide variation. Okada et al. 2004 reported low levels of P. gingivalis and 
A. actinomycetemcomitans as well and absence of P. intermedia in healthy children 
between the ages of 2 and 12 years; however, these percentages increased to over 20% in 
the biofilm of subjects with clinical periodontitis as defined by attachment loss of greater 
than 3 mm on at least one site of 4 teeth. Other studies have found high levels of 
periodontopathgens in periodontally healthy subjects with no differences in levels among 
periodontal healthy and diseased subjects. (Gafan et al. 2004, Lamell et al. 2000). Since 
periodontal examinations were not performed in this study, a positive IgG response is not 
indicative of a clinical diagnosis of periodontitis. 
The majority of studies have shown an association between IgG responses and 
presence of pathogens in the biofilm of children (Savitt et al. 1991, Kojima et al. 1997, 
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Nakagawa et al. 1994a). Periodontitis status in children has also been positively 
associated with IgG response especially with P. gingivalis and A. actinomycetemcomitans
for whom higher levels were noted with increasing disease severity (Kojima et al. 1997, 
Bimstein et al. 2004, Donley et al. 2004). However, other studies have found no 
relationship between serum IgG responses and presence of bacteria in the plaque biofilm 
(Morinushi et al. 2000, Bimstein et al. 2004) or periodontal status (Doty et al. 1982).  
Longitudinal analysis in young children recognize that exposure to periodontal 
pathogens occurs early but may be episodic (Ebersole et al. 1991). After exposure to 
periodontal pathogens serum IgG levels become elevated and usually remain stable 
(Donley et al. 2004) even when bacteria are not found in the biofilm. This may be due to 
protection by an appropriate immune response or failure of bacteria to survive in non-
anaerobic conditions in children (shallow pocket). Another factor that is not addressed in 
this present or the Donley et al. (2004) study is the presence or absence of disease. High 
levels of antibody production with presence of disease may indicate production of 
ineffective IgG antibodies and this may even contribute to disease severity (Kojima et al. 
1997). Magnusson et al. 1991 found elevated serum IgG levels to P.gingivalis, 
A.actinomycetemcomitans and E. Corrodens in refractory periodontitis patients.
Smoking is a known risk factor for periodontitis accounting for increased disease 
prevalence and severity in adults (Tomar et al. 2000). Self reported smoking represented
only a small proportion of this young cohort of children (3.9%). Duration and dose of
smoking increase disease risk; however, due to the younger age of the subjects neither of 
these factors was reported in this study. Few studies exam the association between 
smoking and periodontitis risk in children. A recent study in 12–21 year old Chilean 
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students estimated the risk for chronic periodontitis in smokers and nonsmokers to be the 
same (Lopez et al. 2001). The study sample however smoked on average 5.4 cigarettes 
per day for 3 years, which is a relatively low but early exposure to cigarette smoking. It is 
known that adult periodontitis patients who smoke exhibit a reduction in total serum IgG 
levels and associated increase in periodontal destruction (Graswinkel et al. 2004). This 
suggests a reduction of the protective effect of serum IgG against periodontal pathogens.
H. pylori infection is considered to be etiologic for gastritis and peptic ulcers and 
is a risk factor for gastric cancer (Graham, 1991). Approximately 10% of the population 
are affected by gastric ulceration throughout their lifetime, and more than 50% of people 
are carriers of this bacterium (Souto et al. 2008). Previous studies suggest that childhood 
is a high risk time for acquiring H. pylori infection. Mode of transmission of H. pylori is 
uncertain, many of the current theories suggest that the most probable pathways of
horizotal transmission of H. pylori are through oral-oral, fecal-oral, or gastric-oral 
contact. Factors such as low socioeconomic level, poor hygienic conditions and
overcrowding have been implicated (Wong et al. 2005). H. pylori has been detected in 
the oral biofilm of 41% of adult periodontitis subjects; hence, periodontal pocketing and 
inflammation may favor the colonization by this species in the oral cavity (Dye et al. 
2008). CVD risk has also been shown to be increased in subjects exhibiting positive IgG 
responses to H. pylori (Whincup et al. 2000). Immune responses to this bacterium may 
further compound the overall chronic systemic inflammatory burden. In this group of 
young people 6.9% exhibited an IgG response to H. pylori with girls having statistically 
significant higher proportion of detectable thresholds than males (P<0.01). 
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For this study, the assumption was that an antibody response indicates systemic 
exposure to an oral organism independent of the periodontal status.  Due to majority of 
studies supporting the association between IgG response and periodontal status, 
comparisons of IgG responses as a surrogate marker of exposure are appropriate. For 
children, the majority of studies have focused on a few of the more commonly associated 
periodontal pathogens, including P. gingivalis and A. actinomycetemcomitans. The 
present study found IgG response to P. gingivalis in 5.8% of subjects which is lower than 
other studies who had positive IgG responses in 52% of subjects aged 2 -12 years 
(Donley et al. 2004). These differences may be associated with smaller sample size and 
the demographic and health and periodontal status of the subjects studied. Among the 
bacteria studied, P. intermedia were responsible for an IgG response in over 50% of the 
children. Nakagawa et al. (1994b) found a statistically significant increase in the 
proportions of P. intermedia and serum antibody levels against P. intermedia among pre-
pubertal gingivitis subjects. Serum levels of testosterone in boys and estradiol and 
progesterone in girls was positively correlated with levels of P. intermedia and P. 
nigrescens and increasing gingival inflammation.
Studies analyzing epidemiological data on periodontitis report slight increased 
prevalence of localized aggressive forms among young Caucasian females over males 
(Albandar et al. 2002). More females in this study had significantly higher IgG responses 
to P. micros and A. actinomycetemcomitans, which may reflect a difference in bacterial 
composition or host response from that in males due to the earlier onset of puberty. It is 
known that hormonal variations which occur near puberty increase the prevalence of 
gingivitis in some individuals (Nakagawa et al. 1994b; Mariotti et al. 1999). These 
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changes may encourage the development of pathogenic strains, and increased numbers of 
bacteria which could lead to an increased immune response as evidenced by the increased 
IgG response to bacteria in females (see Table 3). Hørmand & Frandsen, (1979) found 
that females were five times more likely to develop localized aggressive periodontitis 
between 12 and 18 years old. They attributed this to the earlier eruption pattern of 1st
molars and incisors in girls. 
In this current study, African Americans were more likely to produce IgG 
antibody to pathogens than Caucasians. Increased levels of IgG to red and orange 
complex bacteria as well as A. actinomycetemcomitans may confer higher risk for 
initiation and progression of periodontitis (Criag et al. 2002). This is in accordance to the 
increased prevalence of periodontitis reported in this racial group (Albandar et al. 2002). 
According to this data from the NHANES III survey, aggressive and chronic forms of 
periodontitis were reported to be more prevalent in African-American children than in 
Caucasians. There also appear to be differences in the bacterial subgingival colonization 
in African Americans and similarly, an increased prevalence and severity of periodontitis 
(Craig et al. 2002). Differences in host response to bacterial colonization, including 
serum antibody levels, have also been demonstrated among the various ethnic/racial 
groups (Gunsolley et al. 1990) with African Americans having elevated serum antibody 
to A. actinomycetemcomitans. The differences in bacterial colonization and host response 
point to mechanisms that may account for the increased prevalence and severity of 
periodontitis observed in African Americans. 
The early colonization by periodontal pathogens and the associated elevated 
immune response may either offer protection to the host or the immune response may be 
22
insufficient or possibly contributory to the disease process manifesting in attachment loss 
and bone loss (Albandar et al. 2001). Despite focused research in this area, the 
relationship between specific IgG antibody and protection against periodontal pathogens 
remains obscure. Some studies found high antibody levels against periodontal pathogens 
to be associated with disease stability and other studies detect no apparent antibody effect 
on disease activity (Kinane et al. 1999). From this group of children, in which a number 
were overweight/pre-diabetic or healthy, it can be concluded that gender and race may 
represent increased risk for elevated immune responses to the periodontal pathogens. 
Obesity and diabetes are known risk factors for periodontal disease (Genco et al. 2005) 
and the increase in IgG response in this group may be because of the high number of 
cases presenting with overweight +/or prediabetes. This will be reported in subsequent 
papers (Champagne et al. in preparation).
A potential for improving periodontal risk assessment especially in the mixed 
dentition when traditional clinical examination may be difficult due to eruption patterns, 
would be to also assess the IgG responses to known periodontopathogens. Knowledge of 
the patient’s pathogenic exposure may alter the maintenance/intervention strategies for 
these at risk groups. Prevention and reduction of the inflammatory burden caused by 
periodontitis may have a profound effect on not only prognosis of periodontal disease but 
other systemic inflammatory diseases. A number of studies have recently correlated 
elevated serum IgG responses of A. actinomycetemcomitans, P. gingivalis and C. rectus
and increased risk of cardiovascular disease (Beck et al. 2005, Pussinen et al. 2004, 
Colhoun et al. 2008).
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To help understand the mechanisms involved in initiation and progression of 
periodontitis, it makes sense to monitor children from an early age, to elucidate both the 
exact role of individual bacteria and the host immune response. As this paper reports, the 
immune/inflammatory burden starts at a very early age and the long term affects on 
overall periodontal and systemic health remains to be seen. The objective of the present 
study was to examine the nature of the immune response to periodontal pathogens and 
help to identify other risk factors in a cohort of children. It was observed that even in this 
young cohort there are variations in immune responses to periodontal pathogens with 
respect to race and gender. The information gained from this exploratory study may help 
to identify persons with disease/disease risk earlier and enable us to implement 
preventive measures for these patients. Longitudinal studies combining clinical and 
immune responses are necessary to unravel the complexities of periodontal disease 
acquisition, initiation and progression. Further research is needed to fully comprehend the 
immune response in periodontitis and its contribution to systemic inflammation, 
especially in patients with other inflammatory disease processes.
This observational study revealed a surprisingly high number of 9-11-
year-old children exhibiting IgG responses to known periodontopathogens. Significantly 
higher proportions of IgG immune responses were noted for girls and African Americans. 
This analysis shows that the immune-inflammatory burden may start very early with 
potential long term local and/or systemic consequences. Future studies are necessary to 
ascertain the impact of low grade chronic immune responses to periodontal pathogens 
and how these responses influence periodontal, as well as systemic health in children.  
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PART 2:
PERIODONTITIS: THE ROLE OF OBESITY, NUTRITION AND
SYSTEMIC INFLAMMATION
Abstract
Recent studies have suggested that obesity and nutrition may be associated with 
periodontal disease. There has been an alarming increase in the prevalence of obesity in 
the United States and across the world. Obesity is a risk factor for many serious systemic 
diseases including CVD and diabetes. The chronic systemic inflammatory and immune 
effects induced by obesity have been linked with many of these morbidities. Malnutrition 
and reduction in antioxidant intake have also been observed to affect inflammatory and 
immune pathways. These two conditions may also increase the host’s susceptibility to 
periodontal disease through its impact on inflammatory and immune parameters. The aim 
of this review is to provide a detailed update on both obesity and nutrition, examining the 
evidence and biological plausibility regarding the impact of nutrition and obesity on 
periodontal disease.
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INTRODUCTION
The initiation and progression of periodontitis is influenced by several 
determinants including patient, social and behavioral factors, systemic aspects, genetics, 
tooth related factors, microbial composition and other “emerging” factors (Nunn, 2003). 
Among the emerging factors that affect periodontal disease, obesity and nutritional intake 
have recently been identified as modifiable factors which could alter the course of 
periodontal disease progression (Genco et al. 2005, Schifferle, 2005). 
Presently the pathogenesis of periodontitis is based on the concept that there is an 
interaction of the plaque bacteria and the host at the gingival crevice leading to the 
destruction of the periodontal supporting tissues (Offenbacher, 1996). The innate defense 
is the first line directed against these pathogenic bacteria and comprises neutrophils that 
phagocytose the bacteria and limit the inflammation to the marginal gingiva (gingivitis). 
In certain susceptible individuals, this bacterial biofilm can evade the host defense 
mechanisms and gain access to the underlying periodontium. This leads to 
lipopolysaccharide (LPS) presentation to the monocyte lymphocyte axis which induces 
an inflammatory response as evidenced by the production of inflammatory mediators 
such as prostaglandin E2 (PGE2), interleukin 1- beta (IL-1B) and tumor necrosis factor –
alpha (TNF-α) (Offenbacher, 1996). These inflammatory cytokines are released from 
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monocytes and macrophages, which can lead to further inflammation and tissue 
destruction This tissue destruction is evidenced clinically as periodontitis where gingival 
inflammation is accompanied by loss of collagen fiber attachment to the root cementum 
and migration of the junctional epithelium apically. If the pathological process is allowed 
to continue or there is robust host response, then resorption of supporting alveolar bone 
may occur (Armitage, 1995). The host response is integral to the clinical presentation of 
periodontitis and other diseases have been postulated to upregulate this inflammatory 
response. This “priming” of the defense cells has been observed when individuals have
contributing exposures such as diabetes, IL-1 gene polymorphisms and increased stress 
(Kornman, 2008).
It has been observed that obesity and malnutrition have significant effects on 
immune, inflammatory and metabolic processes (Fantuzzi et al. 2005, Chapple et al. 
2009). Periodontitis may be exacerbated by the increase in systemic inflammatory burden 
caused by either of these two maladies. Obesity and nutritional habits are usually formed 
in childhood, and concomitant inflammatory burden early on may have detrimental 
effects on periodontal progression. The aim of this review is to discuss the association 
between obesity and nutrition with periodontal disease and to highlight some avenues for 
future research.
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OBESITY
Definition and Classification
Obesity is defined as a condition in which excess body fat has accumulated to 
such an extent that overall health may be negatively affected (Kopelman, 2000).  Body 
Mass Index (BMI) is the most commonly used method for assigning weight 
classification. It is routinely used in doctors’ offices as well as in epidemiological and 
clinical studies to assess obesity status. BMI is a measure of body mass or weight in 
relation to height and calculated by dividing the weight in kilograms by height in meters 
squared (kg / m2). A BMI of greater than 25.0 is considered overweight and a BMI of 
greater than 30 is considered obese (Kopelman, 2000). (See table 1 for definitive 
classification). Childhood obesity is defined as a body mass index for age and gender that 
is greater than the 95th percentile (Fig.1) (Barlow et al. 1998). 
Table 1. Classifications for Body Mass Index (BMI). Modified from Kopelman et al. 
   2000
BMI(kg/m2) Weight classification
<18.5
18.5–24.9
25.0–29.9
30.0–34.9
35.0-35.9
40.0+
Underweight
Normal weight
Overweight
Obese class I
Obese class II
Obese class III
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BMI scores have been criticized due to overestimation of obesity levels especially 
among more muscular men who usually have an increased BMI without accompanying 
body fat increase (Kopelman, 2000). Abdominal obesity (waist circumference of > 40 
inches) or waist-to-hip ratio (WHR), which looks at the proportion by which fat is 
distributed around the torso, may be more accurate measures of obesity-related 
morbidities and mortalities (Janssen, 2009). 
Fig. 1 Growth chart used to calculate BMI for a 10 year old boy (CDC, 2006)
Other methods of assessing obesity involve using calipers to assess skinfold thickness at 
various sites, is an accurate measure of subcutaneous fat (Jackson et al 1978).  
More recently, bioelectrical impedance analysis (BIA) has been used for 
estimating body composition. BIA can determine the electrical impedance, or opposition 
to the flow of an electric current through body tissues which can then be used to calculate 
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an estimate of total body water (TBW). TBW can be used to estimate fat-free body mass 
and, by difference with body weight, body fat percentage (Kopelman, 2000).
Unfortunately, methods other than BMI and WHR have not proven to be superior, and 
current evidence suggests they are of limited use. Body fat percentage measurement 
techniques used mainly for research include computed tomography (CT), magnetic 
resonance imaging (MRI), and dual energy X-ray absorptiometry (DEXA). These 
techniques provide very accurate measurements, but it can be difficult to scan the 
severely obese due to weight limits of the equipment and insufficient diameter of the CT 
or MRI scanner. It is generally agreed that men with more than 25% body fat and women 
with more than 33% body fat are obese (Haslam, 2000)
Prevalence and Causes
The prevalence of obesity and diabetes is increasing in the United States and 
around the world not only in adults but also in children and adolescents as well. For the 
United States, prevalence of obesity among adults has doubled, and the prevalence of 
overweight among children and adolescents has tripled over the last 20 years. 
Approximately 31% (59 million) of adults in America are now classified as obese and 
15.8% of children aged 6–11 years, and 16.1% of adolescents aged 12–19 years, are 
overweight. In 1990, four states had obesity prevalence rates of 15–19% and no states 
had rates at or above 20%. In 2005, only four states had obesity prevalence rates less than 
20%, while 17 states had prevalence rates of 25% or greater (fig.3)
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Fig. 2 Prevalence of overweight children and adolescents in the United State (CDC,    
2006)
Obesity is mainly caused by high calorie diet and physical inactivity. In recent 
years, the trend for increasing obesity has been linked to larger portion sizes, processed 
foods, diets high in fat and increased consumption of sweetened drinks (Harnack et al. 
2000). In children the reduced participation in physical exercise due to health and safety 
issues at school and the increased watching of television and video games have also 
added to the problem (Dollman et al. 2005). The risk of obesity is 5.3 times higher in 
children who watch 5 hours of television compared to those that watch 2 hours or less 
(Gortmaker et al. 1996). Genetic variability as well as metabolic rate although minor 
have been implicated in the current obesity epidemic (Haslam et al. 2005).
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Fig.3 Estimated percentage of obese individuals per state in the US for 2006 (CDC, 
2006)
Morbidity and Mortality
Obesity has been associated with increased risk for type 2 diabetes, high blood 
pressure, cardiovascular disease, osteoarthritis, respiratory disorders, gall bladder disease 
and nonalcoholic fatty liver (Gregg et al. 2005). Increases in body fat alter the body's 
response to insulin, potentially leading to insulin resistance. Mortality risks appear to be 
directly related to body mass index, but only in younger and middle-aged, but not older, 
males and females (Freedman et al. 2006). This observation may reflect weight loss 
associated with illness in later stages of life. Therefore, death rates are higher in thinner 
people, a phenomenon known as reverse causation. (Kopelman, 2000). Obesity on 
average reduces life expectancy by 6–7 years (Fontaine et al. 2003). Severe obesity (BMI 
>40) reduces life expectancy by 20 years for men and 5 years for women (Haslam et al. 
2005). According to the Framingham Study, a 2% increase in the death rate occurred with 
each extra pound of weight gained between ages of 50 to 62 years (Hubert et al. 1986). 
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Associations between obesity and type 2 diabetes are consistent in the literature. 
The risk of developing type 2 diabetes is increased 10-fold for obese women and 11.2-
fold for obese men (Field et al. 2001). In the Nurses Health Study, BMI was an 
independent risk factor for diabetes (Colditz et al 1995). Compared with women with 
stable weight the relative risk for diabetes mellitus among women who had a weight gain 
of 5.0 to 7.9 kg was 1.9, 95% CI, 1.5 to 2.3. The corresponding relative risk for women 
who gained 8.0 to 10.9 kg was 2.7, 95% CI, 2.1 to 3.3.  Abdominal obesity appears to 
represent an increased diabetic risk with waist circumference over 40 inches producing a 
3.5-fold increase risk of diabetes (Seidell et al. 1997).  Obesity is also associated with 
“metabolic syndrome”, a combination of maladies including hypertension, insulin 
resistance, dyslipemia and atherosclerosis which are all risk factors for cardiovascular 
disease. Accordingly, obesity may cause up to 12% of heart failure cases in North 
America (Kenchaiah et al. 2004)
Metabolic Syndrome
Metabolic syndrome is recognized as a cluster of risk factors associated with type 
2 diabetes and cardiovascular disease (Alberti et al. 2005). It affects a large number of 
people, and prevalence increases with age. Some studies estimate the prevalence in the 
US to be up to 25% of the population (Alberti et al. 2005). Central obesity is a major 
constituent of metabolic syndrome. The National Cholesterol Education Program (NCEP) 
definition of metabolic syndrome requires the presence of abdominal obesity (waist 
circumference > 88 cm or BMI >30 kg/m2) along with 2 or more of the following factors, 
1) triglycerides > 150 mg/dL; 2) decreased serum high-density lipoprotein (HDL)
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cholesterol (< 50 mg/dL); 3) systolic blood pressure > 130 mm Hg or diastolic blood 
pressure > 85 mm Hg; 4) fasting plasma glucose > 110 mg/dL (NCEP, 2001).
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OBESITY, DIABETES AND SYSTEMIC INFLAMMATION
The adipose tissue (fat) in the body is either stored subcutaneously or around 
organs. It is only in recent years that adipose tissue has been recognized as a complex 
secretory organ participating in physiologic and pathologic processes, including 
immunity and inflammation. Of the cells in adipose tissue, adipocytes are the most 
abundant and secrete a variety of bioactive molecules, known collectively as 
“adipokines”. These protein molecules either act locally or are released systemically 
where they function as signaling molecules to other tissues and organs (Trayhurn & 
Wood, 2004). The most studied adipokines, leptin and adiponectin have a number of 
functions within the body. Leptin, which is predominately secreted from adipocytes 
assists in the maintenance of energy expenditure by decreasing appetite or increasing
metabolism (Friedman, 2000). Leptin acts through the hypothalamus of the central 
nervous system where its receptors are highly expressed. Leptin levels are vital in 
regulating body mass, imitating some of the actions of insulin (by altering glucose uptake 
in muscle and fat cells) and lowering glucose production in the liver (Matsuzawa, 2005). 
It appears that obese persons have elevated leptin levels that do not suppress appetite. 
This leptin resistance may contribute to pathological processes’ associated with obesity 
(Blüher et al. 2009). Leptin resistance has been associated clinically with hypertension, 
atherosclerosis and cardiovascular disease (Reilly et al. 2004). Other than appetite, 
immunological functions of leptin include stimulation of cytokines and increases 
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macrophage phagocytosis (Torpy et al. 1998). Leptin has also been shown to protect T 
lymphocytes from apoptosis and regulate T-cell proliferation and activation (Farooqi et 
al. 2002). 
Another adipokine, adiponectin is secreted from adipose tissue into the systemic 
circulation, but interestingly, levels are decreased in obese subjects. The actions of 
adiponectin within the body include glucose maintenance, insulin sensitivity and fatty 
acid breakdown. Adiponectin possesses anti-inflammatory properties. It has been shown 
to inhibit interleukin-6 (IL-6) production, and induce release of interleukin-10 (IL-10)
and interleukin-1 receptor antagonist (IL-1ra) (Ouchi et al. 2003). Adiponectin also 
reduces induction of intracellular adhesion molecule -1 (ICAM-) and vascular 
intracellular adhesion molecule (VCAM) which helps protect against hypertension and 
atherosclerosis (Farooqi et al. 2002). 
Type II diabetics also exhibit low serum levels of adiponectin. It is hypothesized 
that TNF-α production, which is increased in obese subjects, leads to reduction in
circulating adiponectin levels (Fantuzzi, 2005).  Low levels of adiponectin are also 
associated with an increased risk of CVD and other features of the metabolic syndrome 
(Kumada et al. 2003).
Adipose tissue of obese individuals contains an increased number of macrophages 
and these macrophages appear to be hyperactive in their amount of cytokine secretion. 
Macrophages in adipose tissue of obese individuals produce higher levels of TNF-α, IL-
6, and chemokines compared with those in non-obese persons.  IL-6 and TNF-α are 
consistently elevated in the serum and adipose tissue of obese subjects (Fantuzzi, 2005). 
Increased levels of IL-6 are a potential cause for the increase in acute-phase proteins, 
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such as C- reactive protein (CRP) observed in obese subjects. Elevated CRP levels (>3
mg/ml) in obese patients are associated with risk of progression to type 2 diabetes and 
increased risk of cardiovascular disease (Pradhan, 2007). The pro-coagulant properties of 
IL-6 may lead to elevated plasma concentrations of fibrinogen, plasminogen activator 
inhibitor-1 (PAI-1), and C-reactive protein which may explain the increased risk of 
cardiovascular events in obesity (Ridker et al. 2000). Increased levels of PAI-1 are 
associated with accumulation of adipose tissue especially in central obesity (Mavri et al. 
2001). PAI-1 is produced by adipocytes and stromal cells and prevents the dissolution of 
the fibrin clot by inhibiting fibrinolysis. The development of type 2 diabetes and 
atherogenesis have been directly linked to the increased production of PAI-1 (De Taeye 
et al. 2005). TNF-α can directly lead to insulin resistance by inducing serine 
phosphorylation of the insulin receptor, which inhibits insulin signaling (Simons et al. 
2005)
Abdominal obesity is associated with reduced uptake of insulin by the liver, 
increased hepatic glucose production (gluconeogenesis), release of free fatty acids (FFA), 
resulting in elevation of triglycerides, and insulin resistance (Fantuzzi et al. 2005). 
Increased blood glucose levels from ingestion of excess carbohydrates leads to formation 
of free fatty acids (via increased liver synthesis of free fatty acids) and the formation of 
triglycerides within adipocytes. Insulin secretion in response to increased carbohydrate 
levels also reduces lipolysis further increasing adiposity (Musso et al. 2009). Increased 
plasma FFAs lead to further increase in hepatic gluconeogenesis and increased peripheral 
insulin resistance with down regulation of insulin receptors.  Elevated FFA’s have also 
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been shown to induce apoptosis of B-cells of the pancreas via de novo ceramide 
formation and increased nitric oxide production (Genco et al. 2005)
These elevations in blood glucose levels also induce oxidative stress, thus further 
compounding insulin resistance. Chronic hyperglycemia leads to the formation of 
advanced glycation end products (AGEs) by nonenzymatic glycation of proteins, which 
on binding to their surface receptor for AGEs (RAGEs), induce more ROS and 
proinflammatory events (Lindsey et al. 2009). Although research has not fully elucidated 
the exact mechanisms underlying obesity and systemic inflammation and diabetes it is 
likely that adipokines and cytokines produced by adipose tissue play a central role. The 
increased production of circulating inflammatory cytokines in obesity is hypothesized to 
alter the inflammatory response, a potential mechanism linking periodontitis and obesity.
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OBESITY AND PERIODONTAL DISEASE
One of the earliest studies evaluating how obesity modified periodontal response 
in obese was conducted in obese-hypertensive rats (Perlstein et al. 1977). This study 
demonstrated that the obese rats were more likely to have periodontal disease than 
healthy rats.  They concluded that the hypertrophy and hyperplasia of the walls of the 
blood vessels in the periodontium, could possibly alter the vascular, inflammatory and 
immune pathways. Since this initial animal study, several human cross sectional studies 
have elucidated a significant increase in periodontitis risk in obese individuals. One 
Japanese study showed that BMI and waist to hip ratio were positively associated with 
increased risk for periodontitis. Among the 241 healthy Japanese adults, a BMI ≥ 30 
correlated with an adjusted relative risk (RR) 8.6, 95% CI 1.4-51.4 (Saito et al. 1998).  It 
also appears that upper body obesity, which increases risk of diabetes and CVD (Haslam 
et al. 2005) is also associated with periodontitis risk (Saito et al. 2001). For this study, 
643 Japanese subjects were examined for obesity using BMI levels, body fat (DEXA), 
and waist to hip ratio. Analysis demonstrated significant risk for periodontitis only in 
those subjects with high BMI levels or increased body fat as well as high waist to hip 
ratios. These results suggest that the upper body fat accumulation is more closely related 
to risk for periodontitis. In the US population, analysis of the NHANES III data (Wood et 
al. 2003) showed correlations between body mass index, waist to hip ratio and 
periodontal indices such as clinical attachment loss (CAL), probing depth (PD), gingival 
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bleeding even after adjusting for age, gender, diabetes, smoking and socioeconomic 
status. WHR has the highest F ratio (F=253.32), followed by BMI (F=19.651) however, 
subcutaneous fat was not significant, suggesting distribution of fat may be a important 
factor in the association of obesity with periodontal disease.
More recently, Dalla Vecchia et al. 2005 investigated the association between 
overweight/obesity and periodontal status in a representative population in southern 
Brazil. The 706 subjects were 30 to 65 year old and were defined as having periodontitis 
if  ≥30% of teeth present had CAL ≥5mm. Obesity (BMI>30 kg/m2) significantly 
correlated with periodontitis for females only of which 80% were more likely to develop 
periodontitis. Obese non-smoking females were 3.4 times more likely to be diagnosed 
with periodontitis than normal weight non-smoking females. These results were 
postulated to occur because of the proportion and distribution of fat and muscle among 
males and females. This study potentially highlights the need for additional methods for 
diagnosing obesity other than BMI. 
Recently, Khader et al. 2009 looked at the effect of obesity on prevalence of 
periodontitis in a group of Jordanian patients. The results of this study revealed 
prevalence of periodontitis in 14% of normal weight subjects, whereas 29.6% of 
overweight and 51.9% and obese subjects had periodontitis.  In this analysis increased 
waist circumference and high waist-to-hip ratio were more strongly associated with 
periodontitis risk than BMI. Torrungruang et al. (2005) indicated that BMI was not 
associated with CAL among a Thai population 50 to 73 years old, however they 
concluded that older age diluted the association of obesity and periodontitis due to 
potential confounders, such as increased systemic disease and the high number of 
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edentulous patients in this group. Alabdulkarim et al. 2005 showed that, in a case control 
study, alveolar bone loss is related to obesity (BMI ≥ 30) before the age of 40, but not 
when subjects are 40 years and older. 
Table. 2 Summary of a number of studies demonstrating positive association of obesity 
and periodontal disease
Author Study Type Subjects Results 
Saito et al. 
1998
Cross sectional 241 healthy Japanese 
adults
BMI ≥ 30 = OR 8.6
Nishimura et 
al.
2000 
Case-series N = 79
Subjects with NIDDM
BMI was associated 
with periodontitis in 
NIDDM 
Saito et al. 
2001
Cross-sectional 
Convenience 
N = 643 (512 females,
131 males) 19–79 years
WHR, BMI, and body 
fat were associated with 
periodontitis
Wood et al. 
2003 
Cross-sectional NHANES III
N = 8842 
WHR and BMI
associated with CAL 
Al-Zahrani et 
al.
2005 
Cross-sectional NHANES III
N = 13665
18–90 years
BMI > 30 and high 
waist associated with
periodontitis especially 
in younger
adults (18–34 years)
Buhlin et al. 
2003
Case–control N ¼ 96 50 periodontitis and
46 periodontally healthy
subjects, 36–70 years
BMI > 26 in men and
>25 in women was
associated with
periodontitis
Nishida et al. 
2005 
Cross-sectional N = 372, 20–59 years BMI > 26 was
associated with
periodontitis
*Adopted from Saito et al. 2007
Al-Zahrani et al. 2003 examined the relationship between BMI, waist 
circumference and periodontal disease in a representative United States sample 
(NHANES III). The results were significant only for younger subjects with obesity 
(BMI≥30) being associated with greater risk for periodontitis (OR = 1.76, 95% CI, 1.187-
2.612). They also found that high WC and being of young age had an OR of 2.27 (95% 
CI, 1.48- 3.48). These results again emphasize the influence of fat distribution in the 
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analysis and also, older age may potentially confound the relationship between obesity 
and periodontitis. The increase in other medical conditions and poly-pharmacy associated 
with aging may detract from the relationship (Al-Zahrani et al. 2005). 
Linden et al. (2007) investigated the association between obesity and periodontal 
status among Northern Irish men 60 to 70 years old. This study evaluated whether high 
body mass index (BMI) in early life predicted poor periodontal status in later life. Of the 
2748 subjects obesity was associated with a 77% increase in prevalence of periodontitis 
defined as least two teeth with >6mm CAL loss and PD ≥ 5mm. This cohort study 
showed that weight gain (≥30%) during adulthood increased risk for periodontitis, but 
BMI at 21 years old had no effect on periodontitis risk. In contrast, Reeves et al. 2006 
recently analyzed the NHANES III data set using a sample of non-smokers ranging in age 
from 13-21 years old. Of the 2,452 in the cohort, adolescents aged 17-21 years old had 
increased risk of periodontitis per 1 kg increase in body weight (adjusted OR 1.06, 95% 
CI 1.01-1.09). 
Obesity is associated with various health related choices that impact periodontal 
status (e.g., diabetes, oral hygiene and frequency of maintenance visits) (Al Zahrani et al. 
2005). The association between obesity and periodontal disease has also been shown to 
be independent of type 2 diabetic status (Saito et al. 2005). Although obesity in itself has 
been independently associated with periodontitis risk, a model linking obesity, diabetes 
and periodontal disease has been recognized. Genco et al. 2005 using again a large 
sample from NHANES III (12,367 subjects) were able to demonstrate that obese 
individuals (BMI>30 kg/m2) had statistically significant increased severity of attachment 
loss (P<0.001). The authors concluded that obesity was linked with insulin resistance and 
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associated with high plasma TNF-α level which produced a hyperinflammatory state 
leading to increased risk of periodontitis. However, Saito et al. 2005 analyzed 584 
Japanese women for obesity, glucose tolerance and periodontitis. This study established 
associations for obesity and deep probing depths (OR = 4.3, 95% 2.1-8.9), however, 
neither impaired glucose tolerance nor diabetes were significantly associated with deep 
probing depths. This association has also been observed in children. A case control study 
by Lalla et al. (2006) using 182 children with type 1 diabetes and 180 healthy controls 
found that within this group of six to 18 year old diabetics, BMI was significantly 
correlated with destruction of connective tissue and bone, but duration of diabetes and 
mean hemoglobin A1c (HbA1c) were not.
A recent study (Haffajee et al. 2009) with analysis of 574 subjects using logistic 
regression analysis demonstrated OR of 2.3 (95% CI 1.2-4.5), for an obese individual to 
exhibit periodontitis after adjustment for age, gender and smoking status. Only 
Tannerella forsythia was found in elevated levels in the biofilm of obese individuals with 
healthy periodontal tissues or gingivitis. This may reflect an overgrowth of this organism 
that might increase initiation and progression of periodontitis. Offenbacher et al. 2009 
when analyzing their data related to the Periodontitis and Vascular Events (PAVE) pilot 
study discovered that reduction in serum high sensitivity C- reactive protein hs-CRP 
levels were reduced after preventative or periodontal therapy as compared to the no 
treatment group. However, within this group of 303 subjects who had periodontitis and 
recent history of cardiovascular event, when obesity was considered in the adjusted odds 
ratio, treatment had no effect on reduction of hs-CRP levels. This study demonstrates the 
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impact of obesity on systemic inflammation and need for not only periodontal 
intervention but also obesity counseling to reduce cardiovascular risk.
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BIOLOGICAL PLAUSABILITY
Obesity is a risk factor for numerous chronic inflammatory diseases such as type 
2 diabetes, arteriosclerosis and cholelithiasis (Haslam et al. 2005). The potential 
observational evidence for obesity to increase the risk for periodontitis, another chronic 
inflammatory disease has been discussed above. The proposed mechanisms underlying 
this association are not fully elucidated at present but some lines of evidence exist 
relating the pathogenesis of these diseases. From early animal experiments it was shown 
that obese rats were more likely to develop periodontitis than normal rats (Perlstein et al. 
1977).  This group histologically demonstrated the increased thickening of capillaries of 
the periodontium, causing reduced blood flow and reduction of influx of PMNs for 
defense against periodontal pathogens. Obesity also leads to elevated levels of the pro-
coagulant PAI-1 which may further decrease blood flow in the periodontium. (Mavri et 
al. 2001).
Obesity is commonly associated high circulating free fatty acids levels which 
have been shown to directly cause proliferation of the junctional epithelium and bone loss 
in rat periodontitis lesions (Tomofuji et al. 2005). As mentioned earlier, adipose tissue, 
especially visceral adipose tissue, is an important organ that produces several 
systemically active substances known as adipocytokines. The secretion of these cytokines 
may affect periodontal tissues. Tumor necrosis factor-α (TNF-α) is secreted directly from 
adipose tissue and may perpetuate periodontal disease progression. One study analyzed 
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gingival crevicular fluid levels of tumor necrosis factor-α in young subjects (Lundin et al. 
2004). This study pointed to a correlation between TNF-α production and BMI ≥ 40. 
Although the subjects did not have periodontal destruction, it was hypothesized that 
TNF-α secreted from adipose tissue in young adults may influence the periodontal status 
in later life. Some studies have hypothesized that the association of obesity with 
periodontitis is inextricably linked with insulin resistance and diabetes. (Genco et al. 
2005). This group postulates that obesity leads to increased TNF- α production from 
adipocytes which inhibit insulin signaling leading to insulin resistance. This altered 
insulin resistance eventually culminates in diabetic associated hyperinflammatory state 
which is further antagonized by chronically increased circulating FFAs in obesity which 
modulate production of TNF-α and IL-10 (Bradley et al. 2008). It is hypothesized that 
this priming of the inflammatory response that causes the immune system to exhibit an 
exaggerated immune reaction to periodontal pathogens. As already mentioned there is 
evidence for the independent association of obesity with periodontitis (Saito et al. 2005) 
and this may be due to the fact that obesity itself produces enough proinflammatory 
cytokines to tip the balance in favor of hyperreponsiveness to periodontal bacteria. 
Proinflammatory cytokines play essential roles in the inflammatory reaction in 
periodontal disease. This influence on surrounding cells and stimulation of lymphocytes 
culminates in a cascade of events leading to upregulation of osteoclasts and bone 
resorption via the receptor activator of nuclear factor-kappa B (RANK)–RANK ligand 
(RANKL)–osteoprotegerin (OPG) axis (Cochran, 2008). 
The adiopkine leptin stimulates the immune system by increasing cytokine 
production and phagocytosis by macrophages and increasing oxidative stress (Fantuzzi et 
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al. 2005). In obesity leptin upregulates adhesion molecules on endothelial cells, leading 
to transmigration of monocytes and therefore increased numbers of macrophages. The 
macrophages associated with adipose tissue produce increased levels of TNF-α and IL-6
and receptors which could lead to a lead to a hyperinflammatory state increasing the risk 
of periodontitis (Nishimura et al. 2001). The adipokines have also been shown to induce 
reactive oxygen species (ROS) production leading to upregulation of  redox-sensitive 
gene transcription factors, such as nuclear factor–kappa beta (NF-κB) and activating 
protein- 1 (AP-1) further enhancing inflammatory cascades and oxidative stress (Chapple 
& Matthews, 2007a). 
Although reports consistently point to an association between obesity and 
periodontitis, more longitudinal randomized controlled studies are necessary to further 
elucidate the complex role of obesity in periodontitis. However, due to increased risks for 
diseases associated with obesity and the potential impact on periodontal tissues, 
counseling on obesity is recommended as an important component of patient 
management in the periodontal office. Management and education of obese patients may 
necessitate provision of nutritional information which may also impact periodontal health 
(Chapple, 2009). 
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NUTRITION
Components of a balanced healthy lifestyle usually include maintaining an 
average weight, participating in an appropriate exercise routine, and consuming a 
balanced healthy diet (Al-Zahrani et al. 2005). These lifestyle choices have been shown 
to help reduce the risk for developing several chronic diseases such as coronary heart 
disease and stroke (DHHS, 2000). As already discussed research has shown that obesity 
can be significantly associated with increased risk of systemic (Kopelman et al. 2000) 
and periodontal disease (Saito et al. 2001). However, until recently interest on the effects 
of nutrition in the periodontal literature has been minimal. Revival of interest in the 
association between periodontitis and malnutrition has been largely mitigated through the 
early hypothesis that deficiencies in certain micronutrients may lead to increased 
oxidative stress and a decrease in the body’s ability to combat infection. A significant 
association between poor overall diet quality and higher periodontitis prevalence has 
been recently reported (Al-Zahrani et al. 2005).
Due to the multifactorial etiology of the disease, it can be difficult to find direct 
associations between risk factors and periodontitis. Problems are further increased with a 
potential risk factor like nutrition due to conflicting opinions on what constitutes an 
appropriate balanced diet, the use of self-reported diet analysis in epidemiological studies 
and complications in assessing micronutrient deficiencies among individuals. These 
issues were present in earlier studies, which reported conflicting results regarding 
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associations between several individual micronutrients and prevalence of periodontitis
(Slade et al. 1976, Jacob et al. 1987). Dietary questionnaires have been found to have 
weak associations with serum biochemistry levels of micronutrients and with a lack of 
intervention studies, our ability to draw any solid conclusions on causality have been 
limited (Knutsen et al. 2001).
What Constitutes a Balanced Diet?
Kennedy et al. (1995) developed the healthy eating index which is a useful tool in 
assessing calorie intake with correct proportions of carbohydrates, proteins and fats as 
well as micronutrient and vitamin consumption.  Although the nutritional value of these 
recommendations are adequate for most individuals, small variations in micronutrients 
such as vitamins and minerals may have an effect on periodontal tissues (Chapple, 2009). 
Much of the basic research thus far has tested nutrient mechanisms in chronic disease 
processes other than in periodontal disease; hence, there is a need to consider the 
influence of nutrient mechanisms and inflammation associated with periodontal disease. 
Dietary choices are usually based on price, ease of preparation and taste with 
frank disregard to supplying nutrients to the body (Howarth et al. 2007). Although 
malnutrition will most likely result in macro- and micro-nutrient deficiency, it is also 
important to note that obese individuals are more likely to consume a diet high in fatty 
acids and refined carbohydrates and lacking essential vitamins and antioxidants (Mann, 
2002). Using data from the National Health Interview Survey it was estimated that on any 
given day, nearly 50% of the population did not eat any fruit, 80% consumed no 
vegetables, and most diets were low in vitamin A and C rich foods as well as dietary fiber 
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(Patterson et al. 1995). Based on these findings it is likely that periodontal patients are 
likely to be making poor dietary choices. 
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NUTRITION AND PERIODONTAL DISEASE
The mechanism underlying the association between diet and periodontitis could 
be related to the local and/or systemic effects of nutrition on periodontal health. The type 
of food consumed has been linked to the development and survival of plaque biofilm, by 
providing a direct nutrient source or by altering its surrounding environment (Bowden et 
al.1997). Also a diet composed of course, firm foods (i.e., nuts and vegetables) has been 
suggested to reduce plaque accumulation, while a softer diet may promote plaque 
accumulation and therefore contribute to the periodontal disease progression (Newman et 
al. 1974). Nutrition is acknowledged to have a significant impact on optimal functioning 
of the immune response (Boyd et al. 2003).
Malnutrition is characterized by depletion of antioxidants, immune dysfunction, 
reduction of T lymphocytes and hormonal disturbances with increased cortisol levels in 
blood and saliva (Hughes et al. 2008). Periodontal infections may be adversely affected 
by malnutrition with alterations in the oral microbial flora as well as reductions in saliva 
production and its antibacterial components (Enwonwu, 1995). Studies linking nutritional 
status and periodontitis have largely focused on a number of micronutrients including the 
Ascorbic acid (vitamin C), vitamin B-complex, and calcium levels.
Of the vitamins, ascorbic acid has received the majority of attention largely due to 
its historical association with scurvy, which has pronounced effects on the oral cavity 
(Fain et al 1998). Other forms of periodontal destruction have been noted with the 
56
reduction of vitamin C intake. Melnick et al. (1988) examined 60 necrotizing ulcerative 
gingivitis (NUG) patients comparing them to 60 matched controls. Those patients with a 
history of NUG had a statistically significant reduction in ingestion and plasma levels of 
ascorbic acid. Initial studies on vitamin C deficiency in Guinea pigs were carried out by 
Glickman, (1948). Histology revealed that animals on a vitamin C deficient diet for 30 
days developed deeper probing depths, edema and hemorrhage in the periodontal tissues. 
Lack of Vitamin C was proposed to cause a reduction in connective tissue, inflammatory 
cells, and inhibit fibroblast proliferation. A study conducted by Waerhaug, (1958) on 
vitamin C-deficient monkeys demonstrated increased osteoclastic activity leading to 
increased alveolar bone resorption. 
Table 3. Studies showing positive associations with nutritional deficiencies and 
periodontal disease
Author Study Type Nutrient Deficiency Results 
Glickman et al. 
1948
Animal; Guinea 
Pig 
Vitamin C (none-30 days) Increased periodontal 
inflammation and 
destruction
Vogel et al.
1979
Cross sectional, 35 
periodontitis 
subjects matched 
with 1222 controls
Vitamin C (4 day diet analysis) Periodontitis patients had 
significantly lower vit. C 
consumption 
Nishida et al. 
2000
Cross-sectional 
using 12,976 from 
NHANES III
Vitamin C (24hr diet analysis)    
and periodontal exam
Low vit. C levels showed 
increased periodontitis    
OR 1.19, 95% CI 1.05-
1.33
Dreizen et al. 
1977
Animal; Monkeys Vitamin B3 (diet deficient) Animals developed NUG 
and NUP
Oliver et al.
1969
Animals; Rats Calcium deficient Osteoporotic alveolar 
bone changes and 
reduction in periodontal 
ligament fibers
Nishida et al. 
2000
Cross Sectional Calcium (24hr dietary recall) Statistically significant, 
relationship to 
periodontitis (OR: 1.84–
1.99)
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One early study (Vogel et al. 1979) analyzed United States data from NHANES I 
to discern if nutritional status had an impact on periodontitis risk. A four day diet analysis 
was conducted on a small sample of 35 patients (19 females 16 males) between 22 to 59
years old and presenting with generalized moderate to severe periodontitis. They 
calculated the amount of calories carbohydrates, fat, protein, sodium, calcium, 
phosphorus, thiamine, niacin, folic acid, fluoride, cholesterol, vitamins A, C, E, and B12
consumed by periodontitis subjects and compared these with 1,222 individuals of the 
general population without periodontitis. Results demonstrated significantly lower levels 
of riboflavin and vitamin C consumption by the periodontitis subjects compared to the
general population but levels were above the recommended daily allowance.  
Interestingly, a large percentage of periodontitis subjects showed deficiency in calcium, 
magnesium, iron, vitamin E and folic acid. Ismail et al. (1983) also found a weak 
association between periodontal disease and vitamin C deficiency in the analysis of 
nutritional and periodontal health data collected from a representative sample of the 
United States. This study also found that intake of ascorbic acid in amounts larger than 
those recommended by the dietary standards does not seem to be associated with better 
periodontal health.
More recently, Nishida et al. (2000a) utilized NHANES III data to assess the 
association between vitamin C consumption and periodontitis. Analysis of over 12,000 
subjects using a 24-hour dietary recall but without information on supplement use was 
conducted to determine the effect of low vitamin C on periodontitis risk. The results 
showed an inverse relationship with vitamin C intake and periodontitis risk (OR 1.19, 
95% CI 1.05 to 1.33). Current and former tobacco users who were taking less dietary 
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vitamin C showed an increased risk of periodontal disease with an OR of 1.28, 95% CI 
1.04 - 1.59 for former smokers and an OR of 1.21, 95% CI 1.02 - 1.43 for current tobacco 
users. 
Studies evaluating the role of vitamin C on periodontal status appear to indicate 
that a weak, but statistically significant effect may be present. In contrast, studies 
evaluating the effects of vitamin C supplementation on the response to periodontal 
therapy have largely failed to show any preventable benefit or strong association between 
such supplements and clinically relevant improvements in therapeutic results. Woolfe et 
al. (1984) found that the Use of supplemental doses greater than the RDA of vitamin C in 
normal human subjects does not have a predictable or strong effect on the gingival 
response to initial therapy. Similarly, ascorbic acid supplementation did not influence 
PMN chemotaxis or responses to experimental gingivitis (Vogel et al. 1986). The role of 
Vitamin C in protection from periodontitis may be related to antioxidant properties which 
can neutralize free radicals associated with increased oxidative stress in periodontitis 
subjects. Vitamin C has also been shown to suppress macrophage production of free 
radicals and is a primary cofactor in collagen synthesis as seen with scorbutic gingivitis
an ulcerative condition of the gingival tissues under conditions of severe vitamin C 
deficiency (Fain et al. 1998). Studies of vitamin C and periodontal disease have produced 
mixed results. Although studies have not shown a clear relation between plasma 
ascorbate levels and inflammatory periodontitis, this epidemiologic evidence of vitamin 
C intake and periodontal disease, especially among smokers, may be of significance and 
warrant further prospective randomized controlled trials. 
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Vitamin B3 (niacin) deficiency in humans is associated with a disease known as 
pellagra, which is endemic in regions such as Africa, China and Mexico. It manifests 
with dementia, diarrhea, dermatitis and eventually death. Although oral manifestations 
are usually confined to the tongue (glossitis), Dreizen et al. (1977) observed the 
periodontal effects of Vitamin B3 deficiency in monkeys. The results showed that the 
animals developed a syndrome similar to pellagra as well as stomatitis. The stomatitis 
also produced a necrotizing gingivitis and periodontitis and an ulcerative and atrophic 
glossitis. Pack et al. (1984) using a double- blind study to determine the effects of a folate 
mouthwash on gingivitis in adults showed that the mouthwash improved gingival health 
topically rather than systemically. The same group however (Pack et al. 1986) showed no 
statistically significant reduction of experimental gingivitis with a 0.1% vitamin B-
complex mouthwash. Intuitively, more longitudinal studies are necessary to demonstrate 
prolonged affects of B-complex vitamins on gingival and periodontal health.
Calcium and vitamin D deficiencies have been evaluated with respect to effects 
on the periodontal disease. Initial animal experiments involving rats found a reduction in 
the amount of periodontal ligament fibers along with reduction in alveolar bone density
when animals where fed a diet deficient of calcium and vitamin D (Oliver et al. 1969). 
When dietary calcium intake was analyzed Using the NHANES III data, it was estimated 
that low calcium intake was associated with increased periodontitis with an odds ratio of 
OR 1.84, 95% CI 1.36 to 2.48 for young males, OR 1.99, 95% CI 1.34 to OR 2.97 for 
young females, and 1.90, 95% CI 1.41 to 2.55 for the older males (Nishida et al. 2000b). 
A longitudinal study demonstrated decreased tooth loss in subjects receiving 
supplemental calcium and vitamin D over 5 years (Krall et al. 2001). However 
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supplemental calcium did not have any effect on periodontal indices in patients with 
untreated periodontal disease (Uhrbom et al. 1984).
The results of these studies seem to suggest that low dietary intake of calcium 
may result in increased risk for periodontal disease but that the effects of taking dietary 
supplemental calcium  on arresting periodontal disease or as adjunctive aid in its 
treatment have not been thoroughly evaluated.  
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NUTRITION, ANTIOXIDANTS AND INFLAMMATION
Although initiated by plaque biofilm the majority of the destruction seen in 
periodontitis is mediated through an inflammatory immune response (Offenbacher, 
1996). The causes of this hyperinflammatory state are multifactorial and at present not 
fully understood.  It is possible that dietary constituents or deficiencies may alter the 
hyperinflammatory phenotype causing a shift in the balance towards a proinflammatory 
or anti-inflammatory response. 
The initial host defense against periodontal pathogens comes from the 
polymorphonuclear leukocytes (PMNs) (Kornman,  2008). After migration through the 
junctional epithelium, PMNs, prompted by bacterial antigens produce reactive oxygen 
species (ROS) during phagocytosis such as superoxide (O2-) and hydrogen peroxide 
(H2O2) (Miyasaki, 1991). Not only are these free radicals released into the phagosome, 
but are also emitted into the extracellular matrix. These ROS contribute to tissue 
destruction by causing lipid peroxidation and upregulation of inflammatory cytokines by 
monocytes and macrophages through activation of the transcription factor nuclear factor 
κB (Chapple et al. 2007a). It has been demonstrated that adult periodontitis patients 
generate higher levels of superoxide in their gingival fluid than healthy controls
(Guarnieri et al. 1991).
Antioxidants are molecules designed to limit oxidation reactions which transfer 
electrons to an oxidizing agent. Antioxidants interact with each other and with other 
metabolites either independently or synergistically (Knight et al. 1998). It is therefore 
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difficult to ascertain the exact role of individual antioxidants as each may depend on the 
function of other members of the group. This leads to controversy when trying to 
determine the effects of depletion of individual antioxidants on periodontal inflammation. 
Most research has therefore focused on the relationship of periodontal disease and total 
plasma antioxidant concentrations. Chapple et al. (2007b) demonstrated that reduced 
levels of total plasma antioxidants and vitamin C resulted in increasing prevalence of 
periodontitis. 
Several studies have demonstrated a correlation between ROS and periodontal 
disease activity (Marton et al. 1993, Schmidt et al. 1996).  Antioxidants reduce damage 
caused by ROS by removing free radicals, seizing transition metal ions, and inducing 
oxidation of other molecules (Linke et al. 2005). Well known antioxidants include 
vitamin C, vitamin E (tocopherol), carotenoids, and reduced glutathione. Vitamin C is a 
powerful scavenger of free radicals and protects against oxidants in cigarette smoke 
(Chapple et al. 2007a). Vitamin E stops the free radical reactions and stabilizes 
membranes but due to limited mobility, it may have reduced antioxidant ability. Studies 
have found that vitamin E may reduce periodontal disease and associated breakdown of 
collagen fibers (Ritchie & Kinane, 2003, Battino et al. 1999).
People consuming diets rich in carotenoids from natural foods, such as fruits and 
vegetables, have been shown to have lower mortality rates and suffer less chronic disease 
(Diplock, 1998). Carotenoids function as radical-trapping antioxidants. Other than 
Papillon-Lefevre syndrome (PLS), very little research exists looking at the role of 
carotenoids in periodontitis. Recent evidence suggests that defects in polymorphonuclear 
leukocyte enzymes involved in oxidative burst are to blame for the syndrome (Noack et 
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al. 2008). The enzyme, cathepsin C, which is defective in the syndrome, plays a major 
role in the formation of ROS (Noack et al. 2008). Affected individuals present with lower 
antioxidant levels and very high superoxide concentrations, therefore it has been 
suggested that a specific antioxidant therapy could be a promising approach in treating 
some PLS subjects (Battino et al. 2001).
Omega-3 polyunsaturated fatty acids (ω-3PUFAs) found in fish oil also possesses 
anti-inflammatory properties. They have been shown to increase antioxidants and reduce 
bone resorption activity (Schubert et al. 2007). ω-3PUFAs have been shown to reduce 
bone loss associated with experimental periodontitis with Porphyromonas gingivalis.
(Kesavalu et al. 2006). ω-3PUFAs supplements have been shown to reduce TNFα 
production by monocytes in patients who expressed high baseline production (Grimble et 
al. 2002 ). Serhan et al. (2008) have shown reduction of bone loss from experimental 
periodontitis in the rabbit model with the novel Use of lipid mediators termed resolvins 
and protectins derived from the ω-3PUFAs, Eicosapentanoic acid and Docosahexanoic 
acid. These resolvins and protectins stimulate resolution of inflammation by preventing 
neutrophil penetration, phagocytosing dead neutrophils, enhancing clearance of 
inflammation and promoting cellular regeneration (Van Dyke et al. 2008). Another study 
examined the effect of a botanical formulation, which included rose hips, a blueberry and 
blackberry mixture, and a grapevine extract (Kornman et al. 2007). Healthy adults with 
elevated C-reactive protein (CRP) who were either positive (IL-1+) or negative (IL-1-) 
for the at-risk IL-1 gene polymorphism randomly received the formulation or a placebo. 
After 12 weeks, IL-1β gene expression was significantly lower than at baseline and than 
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in placebo for IL-1+ and IL-1- subjects. IL-1+ subjects had achieved a statistically 
significant reduction in CRP with the botanical mixture than with placebo. 
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OBESITY, NUTRITION AND PERIODONTAL DISEASE
It is interesting to acknowledge that a diet high in saturated fats or refined carbohydrates 
commonly associated with obesity may also contribute to systemic inflammation due to 
formation of free fatty acids. As noted earlier FFA formation contributes to insulin resistance and 
diabetes, which may both impact on the hyperinflammatory response and potentially increase 
periodontal destruction (Genco et al. 2005). Diets composed of mainly processed foods high in 
refined carbohydrates and fats lead to increased blood glucose and fatty acids levels, which 
create ROS faster than antioxidants can be produced (Yamato et al. 2007).The resultant oxidative 
stress over time may result in chronic systemic inflammation. When glucose and fatty acids are 
chronically elevated the Krebs cycle and electron transport chain become overloaded. The excess 
electrons formed caUse reduction of oxygen and superoxide formation with resultant elevations 
in ROS (O’Keefe et al. 2008)  This dietary oxidative stress has been associated with increases in 
CRP and proinflammatory cytokines (Monnier et al.2006, Bradley et al.2008). Oxidative stress 
caUsed by dietary fats leads to lipid peroxidation with resultant formation of low density 
lipoproteins which become oxidized and bind to toll-like receptors on inflammatory cell 
membranes, triggering NF-κB activation (Chapple et al. 2007a). The combination of obesity 
mediated systemic inflammation and a decrease in antioxidant rich diet could further exacerbate 
the systemic inflammatory state. The oxidative stress and hyperinflammatory condition 
associated with these two risk factors may further predispose patients to increased risk of 
periodontitis by causing an exaggerated response to periodontal pathogens.
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Figure 4.  Model linking nutrition, obesity, systemic inflammation and 
periodontitis
Figure 4 depicts the  potential deleterious effects of periodontal disease on 
systemic inflammation and oxidative stress. The immune responses elicited from 
exposure to periodontal pathogens have been well established (Gunsolley et al. 1990).
Periodontal disease has been linked to numerous inflammatory conditions, such as 
diabetes (Genco et al. 2005), cardiovascular disease (Beck et al. 2005) and rheumatoid 
arthritis (de Pablo et al. 2008). The inflammatory burden caused by chronic periodontal 
disease is postulated to be one of the reasons leading to associations with systemic 
diseases. IgG immune responses to periodontal pathogens have had been associated with 
increased risk for CVD in a number of adult studies (Beck et al. 2005; Pussinen et al. 
2004). The high prevalence of immune responses in children reported in the initial 
portion of document is cause for concern. The long-term exposure to these pathogens and 
67
concomitant immune responses may have profound influence on development of 
inflammatory diseases such as CVD and diabetes. 
68
SUMMARY AND CONCLUSIONS
Obesity and malnutrition have significant effects on inflammatory, immune and 
metabolic processes. Periodontitis may be exacerbated by the increase in systemic 
inflammatory burden caused by either of these two maladies. The dentist is in a prime 
location to counsel on risk factors for periodontitis which include educating patients on 
maintaining appropriate weight and encouraging a balanced nutritious diet. Reduction in 
both of these modifiable risk factors may have a beneficial effect not only on the patient’s 
periodontal health but on systemic health as well. The increased prevalence of obesity in 
children is a serious health concern. Poor nutritional habits, which are usually established 
in childhood, have the potential to further exacerbate systemic inflammation and 
oxidative stress. The long term exposure of this inflammatory burden, coupled with 
increased immune responses to periodontal pathogens in young children, as reported in 
the observational study at the beginning of this document, may further compound the 
issue. 
Additional longitudinal research is needed to ascertain the role that obesity and 
nutrition play in the initiation and progression of periodontitis and the molecular 
mechanisms involved in its pathogenesis. In summary, nutrition factors in terms of 
nutrient intake and adiposity may play an important role in periodontal disease. 
Nutritional intervention studies in patients with inflammatory periodontal diseases are 
needed, and such interventions offer great potential as novel therapeutic strategies. 
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However, until more data becomes available from micronutritional intervention studies 
on periodontitis, advice should be limited to reducing obesity and encouragement of 
healthy balanced diets containing fruits, vegetables and fish oils.
70
REFERENCES
Alabdulkarim M, Bissada N, Al-Zahrani M, Ficara A, Siegel B. (2005) Alveolar bone 
loss in obese subjects. Journal of International Academy of Periodontology 7, 34-8.
Alberti KG, Zimmet P, Shaw J, IDF (2005) Epidemiology Task Force ConsensUs Group. 
The metabolic syndrome--a new worldwide definition. Lancet. 366, 1059-62.
Al-Zahrani MS, Bissada NF, Borawskit EA. (2003) Obesity and periodontal disease in 
young, middle-aged, and older adults. Journal of Periodontology 74, 610-5.
Al-Zahrani MS, Borawski EA, Bissada NF. (2005) Periodontitis and three health-
enhancing behaviors: maintaining normal weight, engaging in recommended level of 
exercise, and consuming a high-quality diet. Journal of Periodontology 76, 1362-6.
Armitage GC. (1995) Clinical evaluation of periodontal diseases. Periodontology 2000 7, 
39-53
Barlow SE, Dietz WH. (1998) Obesity evaluation and treatment: Expert Committee 
recommendations. The Maternal and Child Health Bureau, Health Resources and 
Services Administration and the Department of Health and Human Services. Pediatrics.
102, E29
Battino M, Bullon P, Wilson M, Newman H. (1999) Oxidative injury and inflammatory 
periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen 
species. Critical Reviews in Oral Biology and Medicine 10, 458-76.
Battino M, Ferreiro MS, Bompadre S, Leone L, Mosca F, Bullon P. (2001) Elevated 
hydroperoxide levels and antioxidant patterns in Papillon-Lefèvre syndrome. Journal of 
Periodontology 72, 1760-6.
Blüher S, Mantzoros CS. (2009) Leptin in humans: lessons from translational research. 
American Journal of Clinical Nutrition. 89, 991S-997S.
Bowden GH, Li YH. (1997) Nutritional influences on biofilm development. Advanced 
Dental Research 11, 81-99.
Boyd LD, Madden TE. (2003) Nutrition, infection, and periodontal disease. Dental 
Clinics of North America 47, 337-54.
Bradley RL, Fisher FF, Maratos-Flier E. (2008) Dietary fatty acids differentially regulate 
production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver 
Spring) 16, 938-44.
CDC. (2006) State-Specific Prevalence of Obesity Among Adults — Us, 2005 Morbidity 
and mortality weekly report  55, 985–988
71
Chapple IL, Matthews JB. (2007a) The role of reactive oxygen and antioxidant species in 
periodontal tissue destruction. Periodontology 2000 43, 160-232
Chapple IL, Milward MR, Dietrich T. (2007b) The prevalence of inflammatory 
periodontitis is negatively associated with serum antioxidant concentrations. Journal of 
Nutrition 137, 657-64.
Chapple IL, (2009) Potential mechanisms underpinning the nutritional modulation of 
periodontal inflammation. Journal of American Medical Association 140, 178-184
Cochran DL. (2008)  Inflammation and bone loss in periodontal disease. J Periodontol 
79, 1569-76.
Colditz GA, Willett WC, Rotnitzky A, Manson JE.  (1995) Weight gain as a risk factor 
for clinical diabetes mellitUs in women. Annals of Internal Medicine. 122, 481-6.
Dalla Vecchia CF, SUsin C, Rösing CK, Oppermann RV, Albandar JM. (2005) 
Overweight and obesity as risk indicators for periodontitis in adults. Journal of 
Periodontology 76, 1721-8.
De Pablo P, Dietrich T, McAlindon TE. (2008) Association of periodontal disease and 
tooth loss with rheumatoid arthritis in the US population. Journal of Rheumatology 35, 
70-6.
De Taeye B, Smith LH, Vaughan DE. (2005) Plasminogen activator inhibitor-1: a 
common denominator in obesity, diabetes and cardiovascular disease. Current Opinion in 
Pharmacology 5, 149-54.
Diplock AT. (1998) Defense against reactive oxygen species. Free Radical Research 29, 
463-7. 
Dollman J, Pilgrim A. (2005) Changes in body composition between 1997 and 2002 
among South AUstralian children: influences of socio-economic statUs and location of 
residence. AUstralian New Zealand Journal of Public Health. 29, 166-70. 
Dreizen S, Levy BM, Bernick S. (1977) Studies on the biology of the periodontium of 
marmosets. XIII. Histopathology of niacin deficiency stomatitis in the marmoset. Journal 
of Periodontology 48, 452-5.
Enwonwu CO. (1995) Interface of malnutrition and periodontal diseases. American 
Journal of Clinical Nutrition 61, 430S-436S
Fain O, Mathieu E, Thomas M. (1998) Scurvy in patients with cancer. British Medical 
Journal 30, 1661-2.
Fantuzzi G. (2005) Adipose tissue, adipokines, and inflammation. Journal of Allergic and 
Clinical Immunology 115, 911-9.
72
Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, 
Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. (2002) Beneficial effects of 
leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction 
of human congenital leptin deficiency. Journal of Clinical Investigation 110, 1093-103.
Field AE, Coakley EH, MUst A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. 
(2001) Impact of overweight on the risk of developing common chronic diseases during a 
10-year period. Archives of Internal Medicine. 9, 1581-6.
Freedman DM, Sigurdson AJ, Rajaraman P, Doody MM, Linet MS, Ron E. (2006)The 
mortality risk of smoking and obesity combined. American Journal of Preventive 
Medicine. 31, 355-62.
Friedman JM. (2000) Obesity in the new millennium. Nature. 404, 632-4.
Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. (2005) A proposed model 
linking inflammation to obesity, diabetes, and periodontal infections. Journal of 
Periodontology 76, 2075-84
Glickman I. (1948) Acute vitamin C deficiency and the periodontal tissues; the effect of 
acute vitamin C deficiency upon the response of the periodontal tissues of the guinea pig 
to artificially induced inflammation. Journal of Dental Research 1948 27, 201-10.
Gortmaker SL, MUst A, Sobol AM, Peterson K, Colditz GA, Dietz WH. (1996) 
Television viewing as a caUse of increasing obesity among children in the Us, 1986-
1990. Archives of Pediatric Adolescent Medicine. 150, 356-62.
Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan 
KM, Williamson DF. (2005) Secular trends in cardiovascular disease risk factors 
according to body mass index in US adults. Journal of the American Medical 
Association. 20, 1868-74.
Grimble RF, Howell WM, O'Reilly G, Turner SJ, Markovic O, Hirrell S, East JM, Calder 
PC. (2002) The ability of fish oil to suppress tumor necrosis factor alpha production by 
peripheral blood mononuclear cells in healthy men is associated with polymorphisms in 
genes that influence tumor necrosis factor alpha production. American Journal of Clinical 
Nutrition 76, 454-9. 
Guarnieri C, Zucchelli G, Bernardi F, Scheda M, Valentini AF, Calandriello M. (1991) 
Enhanced superoxide production with no change of the antioxidant activity in gingival 
fluid of patients with chronic adult periodontitis. Free Radical Research Communication
15, 11-6.
Haffajee AD, Socransky SS. (2009) Relation of body mass index, periodontitis and 
Tannerella forsythia. Journal of Clinical Periodontology 36, 89-99.
Harnack LJ, Jeffery RW, Boutelle KN. (2000) Temporal trends in energy intake in the 
Us: an ecologic perspective. American Journal of Clinical Nutrition 71, 1478-84.
73
Haslam DW, James WP. (2005) Obesity. Lancet. 1, 1197-209.
Howarth NC, Huang TT, Roberts SB, Lin BH, McCrory MA. (2007)  Eating patterns and 
dietary composition in relation to BMI in younger and older adults. International Journal 
of Obesity 31, 675-84.
Hubert HB. (1986) The importance of obesity in the development of coronary risk factors 
and disease: the epidemiologic evidence. Annual Review of Public Health. 7, 493-502.
Hughes S, Kelly P. (2006) Interactions of malnutrition and immune impairment, with 
specific reference to immunity against parasites. Parasite Immunology 28, 577-88.
Ismail AI, Burt BA, Eklund SA. (1983) Relation between ascorbic acid intake and 
periodontal disease in the Us. Journal of American Dental Association 107, 927-31.
Jackson JF. (1978) Elevated metabolic rates in obesity. Lancet 30, 739
Jacob RA, Omaye ST, Skala JH, Leggott PJ, Rothman DL, Murray PA. (1987) 
Experimental vitamin C depletion and supplementation in young men. Nutrient 
interactions and dental health effects. Annals of New York Academy of Science 498, 333-
46.
Janssen I. (2009) Influence of age on the relation between waist circumference and 
cardiometabolic risk markers. Nutritional Metabolism Cardiovascular Disease. 
Nutritional and Metabolism in Cardiovascular Disease. 19, 163-9.
Kenchaiah S, Gaziano JM, Vasan RS. (2004) Impact of obesity on the risk of heart failure 
and survival after the onset of heart failure. Medical Clinics North America. 88, 1273-94.
Kennedy ET, Ohls J, Carlson S, Fleming K. (1995) The Healthy Eating Index: design and 
applications. Journal of the American Diet Association 95, 1103-8.
Kesavalu L, Vasudevan B, Raghu B, Browning E, Dawson D, Novak JM, Correll MC, 
Steffen MJ, Bhattacharya A, Fernandes G, Ebersole JL. (2006) Omega-3 fatty acid effect 
on alveolar bone loss in rats. Journal of Dental Research 85, 648-52.
Khader YS, Bawadi HA, Haroun TF, Alomari M, Tayyem RF. (2009) The association 
between periodontal disease and obesity among adults in Jordan. Journal of Clinical 
Periodontology 36, 18-24.
Knight JA. Free radicals: their history and current statUs in aging and disease. (1998) 
Annals of Clinical Laboratory Science 28, 331-46.
Knutsen SF, Fraser GE, Linsted KD, Beeson WL, Shavlik DJ. (2001) Comparing 
biological measurements of vitamin C, folate, alpha-tocopherol and carotene with 24-
hour dietary recall information in nonhispanic blacks and whites. Annals of Epidemiology
11, 406-16.
74
Kopelman PG. (2000) Obesity as a medical problem. Nature 6, 635-43.
Kornman KS. (2008) Mapping the pathogenesis of periodontitis: a new look. Journal of 
Periodontology. 79, 1560-8
Kornman K, RogUs J, Roh-Schmidt H, Krempin D, Davies AJ, Grann K, Randolph RK. 
(2007) Interleukin-1 genotype-selective inhibition of inflammatory mediators by a 
botanical: a nutrigenetics proof of concept. Nutrition 23, 844-52.
Krall EA, Wehler C, Garcia RI, Harris SS, Dawson-Hughes B. (2001) Calcium and 
vitamin D supplements reduce tooth loss in the elderly. American Journal of Medicine 
15, 452-6.
Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, 
Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; (2003) 
Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia 
with coronary artery disease in men. Arteriosclerosis Thrombosis and Vascular Biology
23, 85-9.
Linden G, Patterson C, Evans A, Kee F. (2007) Obesity and periodontitis in 60-70-year-
old men. Journal of Clinical Periodontology 34, 461-6.
Lindsey JB, Cipollone F, Abdullah SM, McGuire DK. (2009) Receptor for advanced 
glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular 
implications. Diabetic and Vascular Disease Research 6, 7-14.
Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, MöbiUs-Winkler S, Schubert 
A, Schuler G, Hambrecht R. (2005) Antioxidative effects of exercise training in patients 
with chronic heart failure: increase in radical scavenger enzyme activity in skeletal 
muscle. Circulation 111, 1763-70.
Lundin M, Yucel-Lindberg T, Dahllöf G, MarcUs C, Modéer T. (2004) Correlation 
between TNFalpha in gingival crevicular fluid and body mass index in obese subjects. 
Acta odontologica Scandinavica 62, 273-7.
Mann JI. (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet 360, 
783-9.
Marton IJ, Balla G, HegedUs C, Redi P, Szilagyi Z, Karmazsin L, Kiss C. (1993) The 
role of reactive oxygen intermediates in the pathogenesis of chronic apical periodontitis. 
Oral Microbiology and Immunology 8, 254-7.
Matsuzawa Y. (2005) Adipocytokines and metabolic syndrome. Seminars on Vascular 
Medicine. 5,34-9.
Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M, 
Juhan-Vague I. SubcutaneoUs abdominal, but not femoral fat expression of plasminogen 
75
activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and 
decreases after weight loss (2001) Diabetologia 44, 2025-31.
Melnick SL, Alvarez JO, Navia JM, Cogen RB, Roseman JM. (1988) A case-control 
study of plasma ascorbate and acute necrotizing ulcerative gingivitis. Journal of Dental 
Research 67, 855-60.
Miyasaki KT. (1991) The neutrophil: mechanisms of controlling periodontal bacteria. 
Journal of Periodontology 62, 761-74.
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. (2006) Activation 
of oxidative stress by acute glucose fluctuations compared with sUstained chronic 
hyperglycemia in patients with type 2 diabetes. Journal of American medical Association 
12, 1681-7.
MUsso G, Gambino R, Pacini G, De Michieli F, Cassader M. Prolonged saturated fat-
induced, glucose-dependent insulinotropic polypeptide elevation is associated with 
adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated 
enteroadipocyte axis as a novel feature of fatty liver. American Journal of Clinical 
Nutrition 89, 558-67
NCEP- Executive summary of the Third Report of The National Cholesterol Education 
Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in 
adults (Adult Treatment Panel III). (2001) Journal of the American Medical Association
285, 2486-97
Newman HN. (1974) Diet, attrition, plaque and dental disease. British Dental Journal
136, 491-7.
Nishida M, Grossi SG, Dunford RG, Ho AW, Trevisan M, Genco RJ. (2000a) Dietary 
vitamin C and the risk for periodontal disease. Journal of Periodontology 71, 1215-23.
Nishida M, Grossi SG, Dunford RG, Ho AW, Trevisan M, Genco RJ. (2000b) Calcium 
and the risk for periodontal disease. Journal of Periodontology 71, 1057-66.
Nishimura F, Murayama Y. (2001) Periodontal inflammation and insulin resistance--
lessons from obesity. Journal of Dental Research 80, 1690-4.
Noack B, Görgens H, Hempel U, Fanghänel J, Hoffmann T, Ziegler A, Schackert HK. 
(2008) Cathepsin C gene variants in aggressive periodontitis. Journal of Dental Research
87, 958-63.
Nunn ME. (2003) Understanding the etiology of periodontitis: an overview of periodontal 
risk factors. Periodontology 2000, 32 11-23
Offenbacher S. (1996) Periodontal diseases: pathogenesis. Annals of Periodontology 1, 
821-78. Review
76
Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, Barrow DA, Couper DJ, 
Stewart DD, Falkner KL, Graham SP, Grossi S, Gunsolley JC, Madden T, Maupome G, 
Trevisan M, Van Dyke TE, Genco RJ. (2009) Results From the Periodontitis and 
Vascular Events (PAVE) Study: A Pilot Multicentered, Randomized, Controlled Trial to 
Study Effects of Periodontal Therapy in a Secondary Prevention Model of Cardiovascular 
Disease. Journal of Periodontology 80, 190-201.
O'Keefe JH, Bell DS. (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial 
dysmetabolism) is a cardiovascular risk factor. American Journal of Cardiology 1, 899-
904.
Oliver WM. (1969) The effect of deficiencies of calcium, vitamin D or calcium and 
vitamin D and of variations in the source of dietary protein on the supporting tissues of 
the rat molar. Journal of Periodontal Research 4, 56-9.
Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. (2003) Obesity, adiponectin 
and vascular inflammatory disease. Current Opinion in Lipidology 14, 561-6.
Pack, A. R. (1984) Folate mouthwash: effects on established gingivitis in periodontal 
patients. Journal of Clinical Periodontology 9, 619–628.
Pack, A. R. (1986) Effects of folate mouthwash on experimental gingivitis in man. 
Journal of Clinical Periodontology 7, 671–676.
Patterson BH, Harlan LC, Block G, Kahle L. (1995) Food choices of whites, blacks, and 
Hispanics: data from the 1987 National Health Interview Survey. Nutrition and Cancer
23,105-19.
Perlstein MI, Bissada NF. (1977) Influence of obesity and hypertension on the severity of 
periodontitis in rats. Oral Surgery, Oral Medicine, Oral Pathology 43, 707-19.
Pradhan A. (2007) Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis 
of glucose metabolic disorders. Nutritional Review 65, 152-6.
Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally M, Localio AR, Rader DJ, Kimmel 
SE. (2004) Plasma leptin levels are associated with coronary atherosclerosis in type 2 
diabetes. Journal of Clinical Endocrinology and Metabolism 89, 3872-8
Ridker PM, Hennekens CH, Buring JE, Rifai N. (2000) C-reactive protein and other 
markers of inflammation in the prediction of cardiovascular disease in women. New 
England Journal of Medicine 342, 836-43
Ritchie CS, Kinane DF. (2003) Nutrition, inflammation, and periodontal disease. 
Nutrition 19, 475-6.
Saito T, Shimazaki Y, Sakamoto M. (1998) Obesity and periodontitis. New England 
Journal of Medicine 339, 482-3
77
Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A. (2001) Relationship between 
upper body obesity and periodontitis. Journal of Dental Research 80, 1631-6.
Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, Yamashita Y. (2005) 
Relationship between obesity, glucose tolerance, and periodontal disease in Japanese 
women: the Hisayama study. Journal of Periodontal Research 40, 346-53.
Schifferle RE. (2005) Nutrition and periodontal disease. Dental Clinics of North America
49, 595-610
Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R, Brett JG, Lamster IB. (1996) 
Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential 
mechanism underlying accelerated periodontal disease associated with diabetes. Journal 
of Periodontal Research 31, 508-15.
Schubert R, Kitz R, Beermann C, Rose MA, Baer PC, Zielen S, Boehles H. (2007) 
Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory 
response of healthy adults. Nutrition 23, 724-30.
Seidell JC, Han TS, Feskens EJ, Lean ME. (1997) Narrow hips and broad waist 
circumferences independently contribute to increased risk of non-insulin-dependent 
diabetes mellitUs. Journal of Internal Medicine. 242, 401-6.
Serhan CN, Chiang N, Van Dyke TE. (2008) Resolving inflammation: dual anti-
inflammatory and pro-resolution lipid mediators. National Review on Immunology 8, 
349-61.
Simons PJ, van den Pangaart PS, van Roomen CP, Aerts JM, Boon L. (2005) Cytokine-
mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: 
evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human 
preadipocytes are potent leptin producers. Cytokine 21, 94-103.
Slade EW Jr, BartUska D, Rose LF, Cohen DW. (1976) Vitamin E and periodontal 
disease. Journal of Periodontology 47, 352-4.
Tomofuji T, KUsano H, Azuma T, Ekuni D, Yamamoto T, Watanabe T. (2005) Effects of 
a high-cholesterol diet on cell behavior in rat periodontitis. Journal of Dental Research
84, 752-6.
Torpy DJ, Bornstein SR, ChroUsos GP. (1998) Leptin and interleukin-6 in sepsis. 
Hormonal and Metabolic Research 30, 726-9.
Torrungruang K, Tamsailom S, Rojanasomsith K, Sutdhibhisal S, Nisapakultorn K, 
Vanichjakvong O, Prapakamol S, Premsirinirund T, PUsiri T, Jaratkulangkoon O, 
Unkurapinun N, Sritara P. (2005) Risk indicators of periodontal disease in older Thai 
adults. Journal of Periodontology 76, 558-65.
78
Trayhurn P, Wood IS. (2004) Adipokines: inflammation and the pleiotropic role of white 
adipose tissue. British Journal of Nutrition. 92, 347-55.
Uhrbom E, Jacobson L. (1984) Calcium and periodontitis: clinical effect of calcium 
medication. Journal of Clinical Periodontology 11, 230-41.
Van Dyke TE. (2008) The management of inflammation in periodontal disease. Journal 
of Periodontology 79, 1601-8.
Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and 
proinflammatory cytokines: Relationships in obesity. Obes Res 2004;12: 962-971
Vogel RI, Wechsler SM. (1979) Nutritional survey of patients with moderate to severe 
periodontitis. Clinical Preventive Dentistry 1, 35-8. 
Vogel RI, Lamster IB, Wechsler SA, Macedo B, Hartley LJ, Macedo JA. (1986) The 
effects of megadoses of ascorbic acid on PMN chemotaxis and experimental gingivitis. 
Journal of Periodontology 57, 472-9.
Waerhaug, J. (1958) Effect of C-avitaminosis on the supporting structures of the teeth. 
Journal of Periodontology 29, 87–97.
Woolfe SN, Kenney EB, Hume WR, Carranza FA Jr. (1984) Relationship of ascorbic 
acid levels of blood and gingival tissue with response to periodontal therapy. Journal of 
Clinical Periodontology. 11, 159-65.
Wood N, Johnson RB, StreckfUs CF. (2003) Comparison of body composition and 
periodontal disease Using nutritional assessment techniques: Third National Health and 
Nutrition Examination Survey (NHANES III). Journal of Clinical Periodontology 30, 
321-7.
Yamato M, Shiba T, Yoshida M, Ide T, Seri N, Kudou W, Kinugawa S, Tsutsui H. 
(2007) Fatty acids increase the circulating levels of oxidative stress factors in mice with 
diet-induced obesity via redox changes of albumin. FEBS J. 274, 3855-63.
